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Abstract 
Explore the physical and chemical properties of 1,2,3-triazole:  
from fluorescence sensor to ligand in metal catalysis 
Yanwei Zhang 
 
1,2,3-Triazole gold (TA–Au) catalysts were developed by Shi’s group and employed in 
several transformations involving propargyl ester rearrangement. Besides the excellent air, 
moisture and thermal stability introduced through triazole ligands, unique chemoselectivity was 
observed for these novel Au(I) complexes. The chemoselectivity allowed the effective activation 
of the alkyne without affecting the reactivity of the allene ester intermediates. These results led 
to the investigation of the preparation of allene ester intermediates with TA–Au catalysts under 
anhydrous conditions. As expected, the desired 3,3-rearrangement products were obtained in 
excellent yields. Besides the typical ester migrating groups, carbonates and carbamates were 
also found to be suitable for this transformation, which provided a highly efficient, practical 
method for the preparation of substituted allenes.  
Previously research results confirmed TA-Au as a chemoselective catalyst in promoting 
alkyne activation with high efficiency and improved ligand economy. TA-Au analogues were 
sequentially revealed as the effective catalysts in promoting allene hydration, giving the enones 
with excellent yields. Furthermore, the gold-catalyzed intermolecular [2+2] cycloaddition of 
propargyl esters was achieved with good stereoselectivity. The ‘silver-free’ condition was critical 
for this transformation, while only a trace amount of [2+2] products were obtained in the 
presence of silver under otherwise identical conditions. 
Additionally, naphthalene-bridged bis-triazole (NBT) compounds were prepared and 
characterized for investigation of their photophysical properties. Unlike our previously reported 
N-2-aryl triazoles (NATs), which gave strong emissions through the planar intramolecular 
charge transfer mechanism (PICT), this newly developed NBTs adopted a noncoplanar 
conformation between triazole and naphthalene, achieving fluorescence through twisted 
intramolecular charge transfer (TICT). 
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Chapter One: Triazole-Au(I) Complex as chemoselective 
catalyst in promoting propargyl ester rearrangements. 
1.1 Introduction 
 
1.1.1 Background of gold catalysis development 
In the past decade, homogeneous gold catalysis has developed rapidly for activating 
sp hybridized carbon transformations.1 Gold catalysis has been applied in numerous 
synthetic applications to achieve previously challenging transformations with higher 
yield or/and better regioselectivity.2 Compared to traditional metal catalysis, gold 
catalysis presents several advantages: 
1) In most reported cases, gold catalyst can act as a strong π-acid towards 
alkynes/allenes and activate the starting material with high selectivity.  
2) The gold catalyst presents highly reactivity while comparing with other transition 
metals such as Pd, Ru, Rh or Cu (< 1 mol % loading for gold vs approximately 10 mol % 
loading for others)  
3) The mechanism of gold catalysis is flexible based on different reaction patterns 
(such as ligand, solvent, temp.), leading to diverse products even with the similar 
starting materials. 
Scheme 1 shows several representative examples from the recently developed gold 
catalysis transformations reported with high yield and low catalyst loading. 
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Scheme 1. Representative Samples from Recent Gold Catalysis Chemistry 
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Of the two most common oxidation states, Au(I) and Au(III), more studies have been 
focused on Au(I) due to easier preparation and better pre-catalyst thermal stability. Most 
often, Au(III) is simply considered as common Lewis acid to activate heteroatoms (such 
as O, N) while Au(I) can serve as π-acid for alkyne/allene activation.3,4 In the gold 
catalytic process, one key step to generate the active catalyst complex is to dissociate 
the Au-Cl bond. The most common method adopted is relying on silver salts as Cl 
scavenger by forming AgCl precipitate. As a result, active cationic gold species were 
afforded with counter anions introduced by the silver salts such as BF4
-, PF6
-, SbF6
-, 
TfO-, and ClO4
-. It is accepted by the research community that Au(I) complexes present 
two coordination sites with 180o linear geometry (although some exceptions exist). The 
actual catalysts involved in alkyne/alkene activation are of the type [L–Au] +, with the 
open coordination site on the opposite side of the ligand (L) for substrate binding.  
Scheme 2. Catalytic Cycle for Au(I) Catalysis for Common Gold Activated Alkyne 
Reaction 
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Given the use of an alkyne as a specific reactive substrate, the mechanism of Nu-H 
(such as alcohol, amine) addition across the C-C triple bond via an Au(I) catalytic cycle 
is shown in Scheme 2. In this process, the stable L-Au-Cl usually serve as catalyst 
precursor to generate the active L-Au+ complex in situ with the removal of the bonded Cl 
counter anion. This newly opened coordination site will facilitate the substrate (alkyne 
utilizing the C-C triple bond) binding. After the coordination, the nucleophile attacks the 
gold activated alkyne complex and forms the corresponding alkene-gold intermediate. 
The final product is formed by proto deauration and meanwhile, the Au cation was 
released for the next catalytic cycle. 
One major drawback in traditional gold catalysis is the stability of cationic gold 
complex, since it tends to decompose (formation of Au(0) species) under raised 
temperature or reductive environment. To improve the stability of gold complex, various 
research groups are focusing on developing novel ligands to increase the stability of 
Au(I) catalyst. 
The NH carbene is one of the most important ligands currently employed in gold 
catalysis.5 The NH carbene has a unique chemical nature for its lone electron pair and 
π-acceptor orbital. On one hand, the lone pair electrons make NH carbene a good σ-
donor to coordinate towards most transition metals. On the other hand, the π-
backbonding from a metal d-orbital to the π* orbital of NH carbene, makes the 
coordination between the metal and NH carbene even stronger (shorter C-M bond) than 
other heteroatom ligands, and thus the stability of the gold-NH carbene complex is 
significantly improved. 
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Another notable primary ligand in gold catalysis is the phosphine ligand.  The 
bonding between gold and phosphine is typically strong, which can help stabilize the 
complex.6 Additionally, unique spatial conformation of several phosphine ligands can 
make the complexes more stable. For example, as shown in Scheme 3, in the 3-D 
structure of XPhosAuCl, the Ar group introduced by XPhos will block one site of the 
linear L-Au-Cl complex due to the irreplaceable spatial geometry expendation.7   
Scheme 3. IPrAuCl and XPhosAuCl Complexes with Improved Au Cation Stability 
 
 
1.1.2 The role of different 1,2,3-triazole as counter ligand ‘X-factor’ in gold 
chemistry  
Triazole compounds have been prepared as a unique heterocyclic structure with 
interesting electronic effect in last century.8 In 2001, ‘Click chemistry’ was first reported 
by Professor Sharpless, which facilitated access to various 1,4-disubstituted 1,2,3-
triazoles with moderate to good yield.9 In a ‘Click chemistry’, the active Cu(I) catalyst is 
generated in situ from Cu(II) salts (such as CuSO4), while using sodium ascorbate as 
the reducing reagent. Additionally, by adding an excess amount of sodium ascorbate, 
the formation of oxidative homo-coupling products could be successfully avoided in late 
stage of the reaction (Scheme 4).10, 11 
6 
 
Scheme 4. One Typical Example of 'Click Chemistry' 
 
One major drawback of ‘Click chemistry’ is that unsubstituted triazole ring could not 
be achieved with NaN3 or HN3 as a coupling partner. To achieve NH-1,2,3 triazole, 
‘Click chemistry’ was modified by using the N-substituted azide with removable 
functional groups (Scheme 5).12 After reaching the 1,4-disubstituted 1,2,3-triazole, NH-
1,2,3-triazole can be synthesized through a simple N-deprotection. This method 
significantly improved the scope of the 1,2,3-triazole synthesis, whereby post-
functionalization was possible at the free NH site of 1,2,3-triazole. 
Scheme 5. Synthesis of NH-1,2,3-triazoles 
 
In 2005, another efficient synthesis method towards NH-1,2,3-triazoles is developed 
by Professor Zard based on the 1,3-dipolar addition between the nitroalkene and 
sodium azide. NH-1,2,3-triazoles with different aryl substituents can be achieved with 
good to excellent yields, only trace amounts of predictable by-products were observed 
(Scheme 6). 13, 14 
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Scheme 6. Thermal Condensation of Nitroalkene and Sodium Azide  
 
Although the synthesis of 4-mono-substituted 1,2,3-triazole has been reported in 
various methods, how to reach 4,5-di-substituted 1,2,3-triazoles still remained challenge. 
In 2008, Professor Shi and co-workers successfully developed the methodology with 
which to synthesize 4,5-disubstituted NH-1,2,3-triazoles based on a Lewis base-
catalyzed cascade condensation (Aza-Henry reaction) using nitroalkene, aldehyde and 
sodium azide as reaction precursors as shown in scheme 7.15 With this method, a 
series of 4,5-disubstituted NH-1,2,3-triazoles were produced with good to excellent 
yields.  
Scheme 7. Lewis Base-catalyzed Cascade Condensation to NH-1,2,3-triazole 
 
Subsequently, the mechanism of this reaction has been investigated. As described 
in Scheme 8, initially, the Henry reaction occurred between the nitroalkene and 
aldehyde, after which, sodium azide addition of the alkene intermediate occurred and 
formed a new azide intermediate. Follow by the elimination of NO2 anion, the desired 
triazole was generated as the final product.  
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Scheme 8. Mechanism for Synthesis of 4,5-disubstituted NH-1,2,3-triazoles 
 
At this stage, Shi’s group focused on the development of triazole post 
functionalization. With the appropriate electrophiles and reaction conditions, N-
substituted 1,2,3-triazole derivatives could be obtained with NH-triazole as a nucleophile. 
However, in this type of reaction, the regioselectivity between N-1 and N-2 substitution 
arose as one major concern. Moreover, the N-1 substitution dominates in most reported 
results due to its thermodynamic stability.16 Shi's group subsequently investigated the 
selective synthesis towards N-2 substituted 1,2,3-triazole derivatives. With 4,5-
disubstituted 1,2,3-triazole derivatives, the increased steric hindrance from the two 
substituents on C-4 and C-5 positions can theoretically block the N-1 nucleophilic sites, 
which will further lead to the N-2 regioselectivity over N-1 (Scheme 9A).17-18 Three 
different approaches were developed to attain the N-2 aryl substituted derivatives with 
base or Cu(I) catalyzed coupling between NH-1,2,3-triaozle and heteroatom substituted 
aromatic compounds (Scheme 9B).  
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Scheme 9. Synthesis to N-2 Alkyl/Aryl Substituted 1,2,3-triaozle 
 
 
Additionally, our group has developed the post-triazole functionalization to obtain 
more complicated 1,2,3-triazoles derivatives through alkylation, vinylation, arylation, 
propargylation and allenation (Scheme 10). 
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Scheme 10. Different Post-triazole Functionalization Discovered by Prof. Shi's Group 
 
 
With all well-developed synthetic methodologies, Shi’s group decided to investigate 
the binding of 1,2.3-triazole as ligand with transition metals (such as Rh, B, Au) and 
examine the reactivities displayed by the novel transition metal complexes (Scheme 
11).19-21 Despite the fact that all these complexes exhibit interesting reactivities, 1,2,3-
triazole Au(I) complexes would be the major focus in this dissertation.  
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Scheme 11. Different 1,2,3-triazole Metal Complexes Obtained by Prof. Shi's Group 
 
 
As mentioned, Au(I) complexes adopt a linear geometry with two coordination sites.  
One coordination site is occupied by a primary ligand, such as N-heterocyclic carbene 
or phosphine ligand. Recent research discovered that the second coordination position 
could be occupied by a weakly bound Lewis donor, such as pyridine, Tf2N
-, OH-, or 
MeCN. These Lewis donor compounds are categorized as ‘X-factors’ (Scheme 12).22 
More and more recent evidence indicated the significant of these ‘X-factors’. 
Subsequently, Shi’s group initiated an effort to evaluate the bonding ability of 1,2,3-
triazole towards Au(I) as ‘X-factor’ and examine the reactivity displayed by the resultant 
triazole Au(I) complexes. 
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Scheme 12. X-factors in Au(I) Catalysis 
 
 
The earliest case of triazole Au(I) complexes was reported in 1998 by Nomiya et al. 
They obtained the triazole Au(I) complexes by using NaOH in acetone with moderate 
yield.23 Our group prepared the neutral 1,2,3-triazole gold complexes with the 
analogous strategy. Simply treating the NH-triazoles with PPh3AuCl in methanol under 
basic conditions at room temperature gave the neutral TA-Au 1.3 and 1.4 in > 90 % 
yield. The 'cationic' complex TA-Au 1.3a was prepared either by the reaction between 
PPh3Au
+X- (prepared from PPh3AuCl and AgX) and benzotriazole or from the addition of 
HOTf to TA-Au 1.3. Both complexes were stable and could be further purified by 
recrystallization to ensure no extra Ag+ or acid remained in the catalysts (Scheme 13).   
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Scheme 13. Examples of Triazole Au(I) Complexes 
       
By using the methodologies introduced in Scheme 13, Shi’s group synthesized a 
library of different benzotriazole gold complexes (Scheme 14). 
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Scheme 14. A Library of Au(I) Complexes with Different Primary Ligands and Triazoles 
 
To investigate the electronic structure of gold-benzotriazole complexes, 31P NMR is 
applied to investigate the chemical shift of triazole gold complexes with different 
benzotriazoles as ‘X-factors’. The 31P NMR chemical shifts of different gold-
benzotriazole complexes together with L-Au-Cl and PPh3Au
+OTf- are listed in the 
following table (Table 1).  
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Table 1. 31P NMR Data of Substituted TA-Au Complexes a 
 
          a31P NMR spectra of different Au(I) samples. 
 
The 31P NMR data in Table 1 clearly showed that with different substituted groups, 
different chemical shifts of benzotriazole gold compounds were observed. The 
theoretically most unreactive Au(I) chloride had the chemical shift of 34.31 ppm. And the 
theoretically most reactive cationic Au(I) complex PPh3Au
+OTf- exhibited the lowest 31P 
chemical shift at 28.80 ppm. All triazole gold complexes 31P NMR data lying between 
these two extreme cases, exhibited a trend which perfectly lined with the electron 
negativity of different N-1 aromatic substitutions. Complex 1.4f was the one which 
contains the most electronic rich R-substituent gave the 31P NMR chemical shift (δ 
31.89 ppm) closest to L-Au-Cl. In contrast, complex 1.4g with the most electronic 
deficient R-substituent gave the 31P NMR chemical shift (δ 29.80 ppm) closest to 
PPh3Au
+OTf-. Based on the diverse chemical shift, the reactivity for different gold (I) 
benzotriazole complexes are tuned with a small range to apply in gold catalysis.  
16 
 
To better evaluate the reactivity of benzotriazole Au(I) complexes and compare the 
catalytic performance of benzotriazole Au(I) complexes with other Au(I) catalysts, we 
chose to study the 3,3-rearrangement of propargyl ester to allene promoted by triazole 
Au(I) complexes.  
 
1.2 Propargyl ester rearrangements promoted by triazole Au(I) complex as 
chemoselective catalyst. 
 
The propargyl ester rearrangement was considered as one of the most important 
reaction modes in Au(I) promoted transformations.24-34 Recent experimental and 
computational mechanistic studies showed that the 3,3-rearrangement to form the 
allene ester intermediate as the key step in this transformation (Scheme 15A).35-37 Both 
experimental and theoretical investigations confirmed the reversibility between allene 
and propargyl ester due to effective activation of both functional groups by the Au(I) 
catalysts. As a result, it was extremely challenging to obtain the allene intermediates 
with good yields.   
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Scheme 15. The Challenge of The Synthesis of Allenes through Au(I) Activated Alkynes 
 
Many strategies have been developed to make the Au(I)-activated allene esters 
react with other proper substrates, forming interesting new products in a cascade 
fashion. Different types of Au(I) complexes have been applied in the investigation of this 
reaction, such as IPrAuCl/AgBF4. In 2006, Nolan et al developed the synthesis to 
indene compounds, which is a good example highlighting the importance of the cascade 
process.38 As shown in Scheme 15B, with the [IPr-Au]+ catalyst, only a trace amount of 
allene was obtained. The major product was derived from the Friedel-Crafts addition of 
the aromatic ring to the gold activated allene. Therefore, selective activation of the 
alkyne over the allene was considered as a significant challenge in gold catalysis. 
Our group reported the synthesis and characterization of the 1,2,3-triazole 
coordinated Au(I) complexes.39-43 As revealed by the X-ray crystal structures (Scheme 
16), both neutral and anionic triazoles can coordinate with the Au(I) cation, forming 
stable TA-Au complexes.44 
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Scheme 16. X-ray Crystal Structures of Two Different Types of 1,2,3-triazole–Au 
Complexes 
 
The crystal structures revealed nearly identical Au-P bond distance of 2.24 Å for 
both the anionic and neutral triazole coordinated Au(I) complexes. The longer Au-N 
bond in TA-Au-2 implies that the neutral triazole dissociates more easily to release the 
coordination site for substrate activation. This new class of compounds offers improved 
thermal stability and substrate stability in the Au(I) promoted hydroamination and 
Hashimi phenol synthesis,45 which makes them interesting novel catalysts in the field of 
gold catalysis. One particular new development of the TA-Au catalysis that attracted our 
attention was the synthesis of α-iodoenone from propargyl esters (Scheme 17).46 
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Scheme 17. Synthesis of α-Iodoenone Compounds from Propargyl Esters 
 
As indicated in Scheme 17A, the typical [L-Au]+ catalyst promoted the sequential 
rearrangement and iodination, giving the thermally, dynamically stable(Z)-isomer.47-49 
The cationic TA-Au catalyst, on the other hand, produced the kinetically favored (E)-
isomer. Notably, treating the allene ester with NIS gave the (E)-isomer (Scheme 17B). 
The typical [L-Au]+ catalyst influenced the allene reactivity, probably through gold 
catalyzed allene activation. The fact that TA-Au gave the dominant (E)-isomers strongly 
suggests that these complexes may be applied as a chemoselective catalyst in alkyne 
activation over allene.  
The reaction of propargyl ester 1-1a with TA-Au catalysts were then investigated as 
shown in Scheme 18. 
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Scheme 18. Chemoselective Activation of Alkyne over Allene by the TA-Au Catalysts 
 
This transformation proceeded smoothly with substrates having both an aromatic 
group on the propargyl side and an aliphatic group on the alkyne side (entries 1-6) as 
shown in Table 2. The desired allene products were formed in excellent yields, with 1 % 
catalyst loading. The electronic density on the aromatic ring did not have a strong 
impact on the transformation: Both electron donating and electron-withdrawing groups 
were suitable for the reaction. Again, no indene by-products were observed in any of the 
tested cases, even with the electron-enriched p-OMe substituted alkyne 1-1d. These 
results highlighted the excellent chemoselective nature of the TA-Au catalyst. 
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Table 2. The Reaction Substrate Scope a 
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aGeneral reaction condition: 1-1 (0.25 mmol) and TA-Au-2 (1.0 mol %) in dry DCM (2.5 mL), the 
reaction were monitored by TLC (2-10 hrs), rt. bTA-Au-1, TA-Au-2 and TA-Au-3 did not catalyze 
the reaction under the standard conditions. 
 
The terminal alkyne 1-1i did not give any product when treated in the presence of 
the TA-Au catalyst, even after an extended reaction time (24 hrs). This was probably 
caused by the preferred 1,2-rearrangement with the formation of the vinyl-Au 
intermediate. The aliphatic propargyl ester (1-1g, 1-1h) also did not give any desired 
allene products although enones from hydrations were produced after a long reaction 
time (24-48h). The crude NMR of the reaction mixtures did not show an evidence of any 
allene products. This may be caused by the high reactivity of the corresponding 
aliphatic allenes under the reaction conditions (activated by TA-Au) and the overall 
better stability of the propargyl ester compared to the aliphatic substituted allenes 
(equilibrium favored the starting material). The reaction of cyclopropyl substituted 
propargyl ester 1-1j with the TA-Au catalyst gave a complex reaction mixture, which 
suggests possible ring opening and sequential cyclization as reported previously.50 
Overall, this study suggests that the propargyl ester rearrangement to form allene is 
highly substrate dependent. This could either be due to the similar reactivity of the 
alkyne and the allene (giving an equilibrium state favoring the alkyne over the allene) or 
it could be due to a preferred alternative migration path (2,3-migration versus 3,3-
migration). In any case, the TA-Au catalyst clearly displayed interesting 
chemoselectivity.  
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To study the feasibility of this migration, we then investigated migrating groups other 
than esters. The results are summarized in Table 3. 
Table 3. Different Migrating Groups a 
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aGeneral reaction condition: 1-4 (0.25 mmol) and TA-Au-2 (1.0 mol %) in dry DCM (2.5 mL), the 
reactions were monitored by TLC (2-10 hrs), rt. 
 
 
As indicated in Table 3, carbonates (entries 1-5) and carbamate (entry 6) were also 
suitable for this transformation. Compared to the allene-acetates, the allene-carbonates 
and allene-carbamate were more stable in water. Notably, although the alkene was 
considered as a readily reactive functional group in gold catalysis, the substrate 1-4c 
was suitable for this transformation, giving the desired allene-ene 1-5c in excellent yield. 
 
1.3 Conclusion 
In this research, we reported the application of triazole-coordinated Au(I) complexes 
as the effective catalysts for the promotion of the propargyl ester, carbonate and 
carbamate 3,3-rearrangement for the synthesis of the corresponding substituted allene 
derivatives. The chemoselective nature of the TA-Au catalysts was clearly 
demonstrated, which makes them an interesting class of new catalysts for promoting 
organic transformations. The application of the allene-carbonates and allene-
carbamates as building blocks for development of new synthetic methodologies is 
currently underway in our group. 
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1.4 Contribution 
Dr. Dawei Wang was the researchers who had first investigated the reaction. 
Together Dr. Wang and Yanwei Zhang were responsible for the substrate scope 
evaluation and manuscript completion for successful submission to Beilstein J. Org. 
Chem.. Detailed X-ray crystallographic data analysis of compound TA-Au-1 and TA-Au-
2 was done by Prof. Jeffrey L. Petersen, C. Eugene Bennett Department of Chemistry, 
West Virginia University. 
 
 
 
 
 
 
 
 
 
 
 
 
26 
 
Chapter Two: Further transformations from allene 
intermediate formed by triazole-Au(I) Complex promoted 
propargyl ester rearrangements. 
2.1 Triazole gold promoted, effective synthesis of enones from propargylic esters 
and alcohols 
2.1.1 Introduction 
Among previous reported Au(I) catalysts, none of them exhibits a ‘real’ 
chemoseletivity towards alkyne over allene. All the allene intermediates generated from 
the corresponding 3,3-rearrangement were further activated by the Au(I) catalysts and 
transformed to other products. As mentioned above, TA-Au complex could selectively 
activate alkyne over allene, the isolated allene analogues have been achieved from the 
Au(I) activated transformation effectively for the first time. These allene analogues alone 
could serve as very interesting reaction precursors.  
Shi’s group successfully synthesized and characterized a library of 1,2,3-triazole 
gold complexes (TA-Au) as effective catalysts. These complexes exhibit significantly 
improved thermal and substrate stability. These results opened up a new strategy in 
tuning gold reactivity through secondary ligand as ‘X-factor’. Herein, we report the 
application of the 1,2,3-triazole-coordinated52 PPh3-Au catalysts in promoting the 
propargylic ester rearrangement and sequential hydration to form the enone with high 
efficiency (0.2 % catalyst loading, up to 97 % isolated yields), unique reactivity 
(combining the chemoselectivity and acidity) and improved ligand-economy (utilization 
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of the much cheaper triazole and PPh3 ligands as compared with NHC ligands). In 
addition, with the significantly improved thermal stability, TA-Au was further applied as 
the effective catalyst in promoting the propargylic alcohol Meyer-Schuster 
rearrangement to give the enones (0.5 % catalyst loading, up to 98 % yields), which 
highlighted the advantage of this complex compared with other conventional L-Au+ 
catalysts. 
As indicated in scheme 19, one advantage of the TA-Au catalyst is the significantly 
low cost of the ligands. Compared with the NHC ligands, the combination of the PPh3 
primary ligand and triazole as X factor, the cost can be only 1,000th that of a single 
NHC primary ligand. Our original intention was to test whether TA-Au could promote 
transformations that previously required the expensive NHC primary ligands (to improve 
the ligand economy of the overall reaction). This initiated our investigation on the enone 
synthesis from the propargylic esters with our TA-Au catalyst. 
Scheme 19. NHC: Good Ligand in Gold Catalysis but at High Cost 
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The gold-catalyzed Propargylic ester 3,3-rearrangement is a well-studied 
transformation.53 One application of this process was the synthesis of enones from 
sequential hydration of the allene-acetate 2-1-2a intermediates.54 Although this 
transformation provided one attractive strategy in preparing enones under mild 
conditions, it suffered from a limited substrate scope due to the side reactions caused 
by the gold-promoted allene activation. One side reaction was the intramolecular 
Friedel-Crafts cyclization of 2-1-2a, giving the indene 2-1-3a.55 As a result, a simple Au(I) 
catalyst, such as PPh3Au
+, gave poor overall yields of the desired enones (5 % 
Ph3PAuCl/AgOTf, < 40 % yields) (Scheme 20).  
Scheme 20. L-Au+: Effective Catalysts Activating both Alkyne and Allene 
 
To overcome this problem, Nolan and co-workers investigated different N-
heterocyclic carbene ligands.56 The more steric hindered [(ItBu)Au]+ complex was 
revealed as the optimal catalyst for the formation of enones with high efficiency (1 % 
loading, up to 98 % yields). The authors have performed comprehensive mechanistic 
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investigations.54 Through both experimental and computational studies, the SN2' water 
addition to the gold-activated alkyne was suggested as the mechanism by avoiding the 
formation of allene (Scheme 21A). This mechanism is further supported by two other 
experimental observations: (i) no enone formation was observed with the t-Bu-
substituted alkyne 2-1-1b (Scheme 21B), and (ii) treating allene ester 2-1-2a with the 
NHC-Au catalyst did not give enone 2-1-4a (Scheme 21C). 
Scheme 21. Proposed SN2’ Addition Mechanism by Nolan 
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2.1.2 Triazole gold promoted, effective synthesis of enones from prypargylic 
esters and alcohols: a catalyst offering chemoselectivity, acidity and ligand 
economy 
Recently, we reported the synthesis of E-α-iodo-enone from a propargylic ester 3,3-
rearrangment followed by the iodination of the allene ester. Interestingly, while all other 
[L-Au]+ catalysts (such as [NHC-Au]+ and [PPh3-Au]
+) gave only the thermodynamically 
stable Z-isomers, the application of TA-Au led to the selective formation of the 
kinetically favored E-isomers. These results suggested that TA-Au was a 
chemoselective catalyst, which could effectively promote alkyne activation without 
interrupting the inherent reactivity of the allene intermediates.46 
Moreover, as shown in Scheme 22A, although the allene ester 2-1-2a is rather 
stable even at elevated temperatures, treatment of this compound with a catalytic 
amount of acid could effectively convert the allene to the desired enones with excellent 
yields. Interestingly, unlike the previously reported NHC-Au complexes (Scheme 21C), 
TA-Au could effectively catalyze the hydration of 2-1-2a at either room temperature or 
elevated temperature, giving the desired enone in excellent yields. This was likely 
caused by the equilibrium shown in Scheme 22B, where a catalytic amount of HOTf 
was released to serve as the Bronsted acid in promoting the hydration. 
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Scheme 22. TA-Au Serves as Bronsted Acid in Hydration Transformation 
 
We then postulated that TA-Au might be the effective catalyst in promoting the 
propargylic ester rearrangement and hydration to give enones. Unlike the previously 
reported [(ItBu)Au]+ catalyst, TA-Au promoted this reaction through a chemoselective 
rearrangement followed by an effective hydration with the same pre-catalysts, which 
therefore provides an alternative to prepare enones compared with the SN2' mechanism 
by the more expensive [(ItBu)Au]+ catalysts. 
As expected, with the TA-Au catalyst, enone 2-1-4 was obtained in excellent yields. 
No indene by-product was observed, which highlighted the chemoselective nature of the 
TA-Au catalyst.  
TfOH was not a suitable catalyst for this reaction since the 3,3-rearrangement did 
not occur with only TfOH. Screening of solvents revealed MeOH as the optimal choice. 
The reaction worked smoothly at room temperature and gave the enone product in 
excellent yields over 24 h. Increasing the temperature decreased the reaction time to 3-
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6 h. As a result, the enones 2-1-4 were obtained with near quantitative yields (> 99 % 
NMR yields) at very low catalyst loading (0.2 %).  
As shown in Table 4, the reaction tolerated large group substrates, giving the 
desired enone in excellent yields and good double-bond selectivity (dominant trans-
isomers). The t-Bu-substituted alkyne 2-1-2b, which was not suitable with the NHC-Au 
catalyst due to the SN2' mechanism, proceeded smoothly under these alternative 
conditions although with slightly decreased Z/E selectivity (2-1-4b). The high efficiency 
makes TA-Au a very attractive and practical catalyst for this transformation: at least 5 
times lower catalyst loading than NHC-Au+ with much less expensive ligands.  
Table 4. TA-Au Catalyzed Propargyl Ester Hydrolysis a, b 
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aGeneral reaction condition: 2-1-1 (1.0 eq.) and TA-Au (0.2 mol %) in wet MeOH (0.25 M), the 
reaction were monitored by TLC (3-6 h), 60 oC. bIsolated yields; E/Z ratios were determined by 
1H NMR. 
 
Heating the [(IPr)AuCl]/AgBF4 in wet MeOH at 60 
oC produced a black 
solution/participate within 30 min, indicating the rapid decomposition of the catalyst. In 
contrast TA-Au, on the other hand, showed much improved stability, with no 
decomposition after more than 6 h under the same conditions. Considering the good 
thermal stability of TA-Au, we wondered whether this catalyst could also be used to 
promote the challenging Meyer-Schuster arrangement of propargylic alcohols 2-1-5 at 
higher temperature.57 Impressively, the desired enone products were formed with 
excellent yields. The reaction also tolerated a large group of substrates (Table 5). 
Table 5. TA-Au Catalyzed Meyer-Schuster Rearrangement a, b  
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aGeneral reaction condition: 2-1-5 (1.0 eq.) and TA-Au (0.5 mol %) in wet MeOH (0.2 M), the 
reaction were monitored by TLC (4-12 h), 60 oC. bIsolated yields; E/Z ratios were determined by 
1H NMR. 
 
Surprisingly, the bulky tert-butyl-substituted alkyne 2-1-5b was also suitable for this 
reaction, which suggested the effective water addition to the sterically hindered alkyne 
at higher temperature. The terminal alkyne propargylic alcohol gave enal in modest 
yields, which were probably caused by the longer reaction time required for the less 
favored anti-Markovnikov addition. 58-59 
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Scheme 23. Comparison with the Best Results Obtained in the Literature 
 
Continuous addition of catalysts could improve the overall yields. Nevertheless, the 
feasibility of this challenging substrate highlighted the strength of the TA-Au catalyst 
over the [NHC-Au]+ catalyst (Scheme 23) by tolerating the much harsher conditions.60 
 
2.1.3 Conclusion 
In conclusion, we have reported herein the application of triazole-coordinated Au(I) 
complex (TA-Au) as an effective catalyst in promoting propargylic ester rearrangement 
and hydration for the synthesis of substituted enones. The key for the success of the 
TA-Au catalyst was the combination of its unique chemoselectivity and acidity. 
Extension of this transformation to the Meyer-Schuster rearrangement by taking 
advantage of the thermal stability of the TA-Au further improved the atom economy. 
Compared with the more expensive NHC-Au catalysts, TA-Au promoted the reaction 
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through a different mechanism and achieved better performance with lower overall 
costs. 
 
2.1.4 Contribution 
Dr. Dawei Wang was the researcher who had first investigated the reaction condition 
and mechanism investigation. Together, Dr. Wang and Yanwei Zhang were responsible 
for substrate scope, NMR spectrum, and manuscript completion for successful 
submission to Advanced Synthesis and Catalysis.  
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2.2 Ambient Intermolecular [2+2] cycloaddition of allene intermediate 
2.2.1 Introduction 
As mentioned, Au(I) catalyzed alkyne transformations typically undergo 3,3-
rearrangement. The allene intermediates can be further activated by the same gold 
species and converted into various products, such as indenes, enones, and vinyl 
halides. 
Scheme 24. Gold-catalyzed Propargyl Ester Activation 
 
The formation of indene, enones and E-α-haloenones has been introduced in 
chapter 1 and 2.1. One more important application of allene substrate is the 
intermolecular [2+2] cyclization forming the multiple substituted cyclobutane. In this 
transformation, TA-Au complexes chemoselectivity was applied in the well-developed 
process of forming an allene intermediate. The allene intermediate then facilitated the 
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[2+2] cyclization process, achieved the cyclobutane under the absolutely 'Silver-free' 
condition. 
 
2.2.2 'Silver effect' in homogeneous gold (I) catalysis 
 
Along with the development of gold catalysis, it is possible to get some traditionally 
challenging transformation to occur by tuning the reactivity of gold complexes with 
different primary ligands. However, it still remains one critical issue in gold catalysis, 
which is referred as ‘Silver effect’ in the transformations. As indicated above, silver salts 
are generally adopted to dissociate the Au-Cl bond in L-Au-Cl complex by forming AgCl 
precipitate. Because these cationic gold complexes slowly decompose over time, they 
are always freshly prepared right before the reaction setup or generated in situ. 
Typically, the resulting AgCl precipitate can be removed by simply passing the 
reaction solution mixture through cotton plug or filter paper.61 However, recent research 
indicates that: a) practically, more than necessary silver salt is applied in the reaction 
mixture, therefore, not all Ag+ is converted to AgCl precipitate. The additional amount of 
Ag+ left in the catalyst system affects the transformation; b) in presence of Au+ and Ag+, 
an unexpected Au-Ag di-metal co-catalysis system is observed in the resting state and 
leads to diverse reaction patterns.  
The first evidence for Au-Ag di-metal co-catalysis was published in 2009. For first 
time, researchers realized that silver presented a more significant effect in the catalyst 
system behavior other than just forming AgCl precipitate (Scheme 25).62 
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Scheme 25. Different Resting States in the Au(I) Catalysis when Silver is Presented 
 
As shown in Scheme 25, there were two resting states of Au(I) activated Friedel-
Crafts reaction in this transformation. One (2.6) was established with two Au+ atoms, 
and the other one (2.7) was formed with one Au+ and one Ag+. The ratio of these two 
resting states was differing based on the amount of silver salt introduced in the reaction 
mixture. Although these two very similar resting states gave the identical product in this 
specific case, the reaction rates were significantly different. Furthermore, by adding an 
excess amount of AgNTf2, the reaction was quenched (Scheme 26B).
63 
This case demonstrated that in gold catalysis, Ag+ might serve as an important 
candidate which participated in the catalysis pattern. Subsequently, more and more 
effort has been devoted to investigating the mechanism of ‘silver effect’ in gold catalysis. 
Additionally, to better understand ‘silver effect’, ‘silver free’ gold catalyst system is 
desired as standard in gold catalysis. 
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Scheme 26. The Reaction Rate is Slowed Down by Adding AgNTf2 
 
In 2007, the original 'silver free' Au(I) catalyst was developed by Prof. Gagosz et al. 
The bis(trifluoromethanesulfonyl)imidate moiety (Tf2N
-) was applied as the counter ion 
for Au(I) complexes (Scheme 27A). It was shown that AuNTf2 is stable enough to 
perform a recrystallization purification and obtain the 'silver free' gold complexes as a 
crystal solid.64 As mentioned above, the coordination between gold cation and Tf2N
- is 
weak and enabled the significant ligand exchange between the Tf2N
- and reacting 
substrates without influencing the reactivity of gold catalysts (Scheme 27B).65 
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Scheme 27. Synthesis and Application of [IPrAuNTf2] 
 
The triazole gold complexes are also able to achieve the 'silver free' crystal by 
recrystallization due to their moisture and air stability. As a consequence, triazole gold 
complexes provide us a good ‘silver free’ model to investigate the 'silver effect' in gold 
catalysis. To comprehensively understand the function of Ag+ in gold catalysis, an 
alkyne hydration reaction was investigated with both Au-Ag co-catalysts and ‘silver free’ 
Au(I) catalysts (such as TA-Au). The consequences of different gold catalysts are 
summarized in Table 6. 
Table 6. Silver Effect in Alkyne Hydration a 
 
Entry Catalyst Conditions Yield (%)b ee (%) 
1 1 % TA-Au 5 hrs 87 90 
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2 10 % AgX c 12 hrs 0 - 
3 2 % [PPh3Au]
+X- c 12 hrs 0 - 
4 2 % PPh3AuCl/AgOTf 12 hrs 90 0 
5 2 % PPh3AuCl/AgSbF6 8 hrs 97 0 
6 2 % PPh3AuCl/AgOTf 5 hrs (N2) 92 90 
7 2 % [PPh3Au]
+SbF6
- + AgSbF6 12 hrs 91 - 
aGeneral reaction conditions: 2.10 (1.0 equiv) and catalyst in 2.5 mL of dioxane/water (H2O, 3.0 
equiv) at rt. Reactions were monitored by TLC. bNMR yields. cX− = TfO−, SbF6
−, BF4
−. 
 
 
The results indicated that Ag+ by itself did not perform any reactivity towards this 
transformation (entry 2). Additionally, entry 3 (gravity celite filtration) showed that when 
using the ‘silver free’ Au+ catalyst, there was no desired product observed no matter 
what primary ligand was applied. However, when using a mixture of L-Au-Cl and AgX 
(entry 4 and 5, cotton plug or filter paper filtration) as pre-catalyst, the reaction 
proceeded with high yield under the identical conditions. In addition, a high ee value 
was observed as reported under N2 protection (entry 6). To confirm the effect of Ag
+ in 
this transformation, entry 7 was designed with a mixture of ‘silver free’ [(PPh3)Au]
+ OTf- 
and back-addition AgSbF6 (AgSbF6 was added to the reaction mixture after the celite 
filtration). The consistent result was observed as entry 5, which verified this reaction 
was actually catalyzed by Au-Ag co-catalysts. 
The only difference between entry 3 and entries 4, 5 here was the filtration 
precedure. Entry 3 was using a cotton plug or filter paper to remove the AgCl, while in 
entry 4 and 5, celite pipette was used to reach the same target. The gravity filtration 
through the celite pipette was a quite efficient and reliable process to remove all 
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remaining Ag+, which was further confirmed by X-ray photoelectron spectroscopy (XPS) 
(Scheme 28).  
Scheme 28. XPS Spectra of (PPh3)AuCl/AgSbF6 Mixtures  
 
In Scheme 28, both spectra showed the signal of Au+ at the binding energy as Au 
4f7/2, 85.5 eV; Au 4f5/2, 89.2 eV, while the signal of Ag
+ (Ag 3d5/2, 368.7 eV; Ag 3d3/2, 
374.7 eV) was only observed in spectrum A which regular cotton plug or filter paper was 
applied in the filtration step. No corresponding Ag+ signal was observed which indicated 
no presence of silver in spectrum B with celite pipette filtration. This result is sufficient to 
prove that gravity celite filtration procedure is reliable to produce 'silver free' gold 
catalyst even with excess amount Ag+ ((PPh3)AuCl:AgSbF6 = 1:1.5).  
Meanwhile, 31P NMR spectroscopy is applied to inspect the existence of Ag+ in Au(I) 
complexes (Scheme 29). 
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Scheme 29. 31P NMR Spectra of Different Au(I) Species 
 
The data in Scheme 29 released the relationship between chemical shift of 31P and 
the reactivity of Au(I) complexes (more downfield chemical shift, lower reactivity). The 
unreactive (PPh3)AuCl presented the most downfield chemical shift due to the strong 
coordination between Au and Cl. The freshly prepared 'silver free' [(PPh3)Au]
+TfO- 
through gravity celite filtration presented the most upfield chemical shift (which is 
considered as the most reactive catalyst). The (PPh3)AuCl/AgOTf mixture without any 
filtration presented a chemical shift between these two mentioned cases. These results 
indicated that silver here can, to some extent, influence the reactivity of Au(I) complexes. 
 
2.2.3 Ambient intermolecular [2+2] cycloaddition: an example of carbophilicity 
and oxophilicity competition in Au/Ag catalysis 
Recently, special gold catalysts have been reported to achieve high yields of allene 
intermediates, including the triazole gold reported by our group. While this chemistry 
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seems well understood, one 'concealed' problem was that most of these 
transformations generally lack tolerance for the diaryl substituted internal alkynes (R1, 
R2= aryl groups). For example, simply treating diphenyl propargyl ester 2-2-1a (R1 = R2 
= Ph, R = CH3) with various LAuCl/AgX (L = PPh3, IPr, XPhos; X = TfO
−, Tf2N
−, SbF6
−, 
BF4
−) catalysts gave complex reaction mixtures with little indene or allene obtained. In 
order to determine the product for diaryl propargyl ester in presence of gold catalysts, 
we conducted detailed investigations with the diaryl propargyl ester starting material.  
We herewith report the different products formed from this diaryl propargyl ester 
rearrangement and the intermolecular allene [2+2] cycloaddition at ambient temperature. 
In addition, the ‘silver-free’ condition is critical in this transformation. In the presence of 
silver, even a catalytic amount, dimer 2-2-2 was observed over the [2+2] products due 
to the silver-activated substitution. Considering the extensive efforts from various 
research groups toward understanding the role of silver in gold catalysis, this work 
provides another example of silver influence as an oxophilic Lewis acid, which deviates 
from the gold reaction pathway.66 
The cationic gold complexes are effective carbophilic π-acids, which can effectively 
activate both an alkyne and allene.67 According to the literature, three types of 
chemoselective gold catalyst (activate alkyne over allene) have been reported as gold-
oxo complexes, gold-pyridine/Et3N complexes, and 1,2,3-triazole gold complexes (TA-
Au).68-70 Surprisingly, among all the reported gold-catalyzed propargyl ester 
rearrangements, diaryl propargyl esters are not viable substrates. In fact, during our 
investigations of the triazole gold (TA-Au) catalyzed allene synthesis, complex reaction 
mixtures were observed. In order for us to understand how this particular type of 
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substrate reacts, we monitored the reactions of compound 2-2-1a with various gold 
catalysts (Scheme 30). 
Scheme 30. Analyzing the Propargyl Rearrangement of 2-2-1a 
 
 
 
First, the treatment of 2-2-1a with LAuCl/AgX (5 % loading, L = PPh3, IPr, XPhos, X 
= OTf, NTf2 or SbF6) gave complex reaction mixtures. Through careful examination, 
dimer 2-2-2a was identified as the major product (50 % yield using anhydrous solvent; 
see detailed structure analysis in the Supporting Information). With the triazole gold 
(TA-Au) catalysts, the reaction was much cleaner (less polymerization and 
decomposition). However, several other products were observed in addition to the dimer 
2-2-2a (30 %). Fortunately, the structure of one major product was determined by X-ray 
crystallography as the [2+2] cycloaddition product 2-2-3a. Other minor products were 
identified as the stereoisomers generated from the [2+2] cycloaddition. 
This result was exciting because it was the first example of an intermolecular allene 
[2+2] reaction through a propargyl ester rearrangement. Notably, indene was not 
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observed in this case. The successful confirmation of the dimer and the [2+2] 
cycloaddition products greatly enhanced our understanding of this reaction. A proposed 
reaction mechanism is shown in Scheme 31. 
Scheme 31. Propargyl Ester Activation 
 
Cyclobutanes are very attractive as building blocks in organic synthesis, and this 
reaction is conducted under mild conditions (rt) with simple starting materials. Thus the 
discovery shown above revealed an interesting new approach to access substituted 
cyclobutanes under mild conditions. As shown in Scheme 31, the allene should be 
formed prior to either dimerization or cyclization. This was confirmed by monitoring the 
reaction with NMR: allene A was the only product formed during the first 2 h of reaction 
when treating 2-2-1a with TA-Au catalysts. Efforts to isolate allene A were unsuccessful 
due to the poor stability. In order to improve the chemoselectivity ([2+2] over dimer) and 
stereoselectivity (different cyclobutane isomers), we prepared various propargyl ester 
derivatives and examined them under the conditions of gold catalysis. The results are 
summarized in Table 7. 
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Table 7. Optimization of Au(I)-catalyzed Allene [2+2] a 
 aReaction conditions: 2-2-1 (0.2 mmol) and catalyst in DCM (0.8 mL), rt, time. bDetermined by 
1H NMR using 1,3,5-trimethoxybenzene as internal standard. cTA-H = benzotriazole. dTA-Me = 
N-methyl benzotriazole. e15 % yield of (E)-1-phenyl-3-(p-tolyl)prop-2-en-1-one. 
 
The PPh3AuCl/AgOTf catalysts gave only dimer 2-2-2 with no cycloaddition product 
2-2-3 observed (entry 1). The silver-free TA-Au catalyst produced the desired [2+2] 
products as mixtures of isomers. With the NH-triazole (TA-H) as the ligand, 43 % dimer 
was obtained (entry 2). The amount of dimer was decreased when N-methyl triazole 
(TA-Me) was used (entry 3), probably due to the elimination of an acidic proton on NH-
triazole (activating the OAc leaving group). Switching acetate to benzoylate resulted in 
the exclusive formation of a dimer due to the better propargyl leaving group (PhCOO− 
vs CH3COO
−). Finally, application of pivalate achieved excellent chemoselectivity, giving 
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the [2+2] products in good yields (>85 % combining all isomers, entry 5). Moreover, the 
bulky pivalate group also gave significantly improved stereoselectivity with only two 
major cycloaddition products obtained (2-2-3 and 2-2-3′) in a 5:1 ratio. The structure of 
the minor isomer, 2-2-3′, was also confirmed by the X-ray crystallography. The silver-
free gold oxo catalyst [(PPh3Au)3O]OTf could also promote this reaction effectively 
(entry 6), though with a slightly lower reaction rate compared with the use of TA-Au. 
The silver salt was crucial in this transformation. As shown in entry 7, the addition of 
2 % AgOTf led to the formation of only dimer 2-2-2 without obtaining any cycloaddition 
product 2-2-3 obtained. Using a silver catalyst alone (entry 8) gave the same dimer 
product with a slower reaction rate, likely due to the decreased reactivity of the silver 
catalyst toward alkyne activation (compared with gold catalyst). Triflate acid did not 
promote the rearrangement at all, giving only the propargyl ester decomposition over 
time (entry 9). Finally, the silver-free PtCl2 catalyst gave a similar cycloaddition reaction, 
albeit at elevated temperature (entry 10). In view of these results, it is clear that the 
propargyl rearrangement is the initiation step. The reactivity of the three well-known π-
acids follows the general trend Au(I) > AgX > PtCl2 in this transformation. Besides 
alkyne activation, the silver cation (more oxophilic) can also activate the acetate as a 
leaving group, giving dimer 2-2-2 as the only product. The silver-free TA-Au catalyst 
indicated excellent reactivity toward alkyne activation over the undesired oxygen 
activation, which led to the successful cycloaddition of allene for the first time. The 
scope of reaction substrate is shown in Table 8. 
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Table 8. Reaction Scope of [2+2] Cycloaddition a, b 
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 aReaction conditions: 2-2-1 (0.2 mmol) and [PPh3Au(TA-Me)]OTf in DCM (0.8 mL). 
bDetermined 
by 1H NMR using 1,3,5-trimethoxybenzene as internal standard. c1 mol % of [(PPh3Au)3O]OTf 
was used instead of [PPh3Au(TA-Me)]OTf. 
 
The reaction tolerates a good substrate scope on the propargyl aryl position (Ar1). 
Electron-withdrawing groups (2-2-3h, 2-2-3k) were suitable for this reaction, giving the 
desired cycloaddition products with good yields. The electron-donating group modified 
substrate (2-2-3i) gave the dimer as one of the major products with TA-Au catalysts, 
probably due to the improved ability to form a propargyl carbon cation. This problem 
was resolved by using [(PPh3Au)3O]OTf as the catalyst with a longer reaction time. 
Steric hindrance was not an issue in this transformation based on the fact that ortho-
substituted substrates (2-2-3l−2-2-3n) worked fine under the optimal conditions with the 
formation of the desired [2+2] cycloaddition products in excellent yields and similar 
isomer ratios. Poor selectivity was observed with naphthalene-substituted derivative 2-
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2-3o (1.8:1). This result implied the plausibility of π−π stacking during the [2+2] 
cycloaddition process. 
A greater electronic effect was observed at the alkyne terminal Ar2 position. The 
electron-donating p-methoxyphenyl substituted alkyne gave the desired cyclobutane 2-
2-3p in excellent yield when [(PPh3Au)3O]OTf was used as the catalyst. However, an 
electron-withdrawing group reduced the reaction rate for propargyl ester rearrangement 
due to either the poor reactivity of alkyne toward π-acid activation (lower electron 
density) or the unfavored 3,3-migration (over the electronically preferred 1,2-
rearrangement). Increasing the reaction temperature to 80 °C (with dichloroethane as 
the solvent) gave the allenes at low yields (< 20 %), along with a significant amount of 
unidentified side products. These results suggest that the ambient [2+2] cycloaddition is 
substrate-dependent, which raises the concern whether gold catalysts were involved in 
the cycloaddition process. To verify the potential role of gold catalysts in the 
cycloaddition step, we monitored the reaction as shown in Scheme 32. 
Scheme 32. Investigation on the Role of Au in [2+2] Step 
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Treating propargyl ester 2-2-1c with silver-free BrettPhosAuNTf2 (0.5 %) gave rapid 
rearrangement (5 min) to allene 2-2-4 in quantitative NMR yield. Because allene 2-2-4 
will decompose upon condensation, it is difficult to isolate 2-2-4 in pure form. Thus the 
reaction mixture was divided into two parts. One part continued to react under the 
identical conditions (in the presence of the gold catalyst). The other part was filtered 
through a silica plug so as to completely remove the gold catalyst. The resulting solvent 
was condensed to ensure a concentration that was identical to that in the case with the 
gold catalyst. As reviewed by NMR, for both cases, similar reaction rates were observed, 
which confirmed that the allene [2+2] cycloaddition was a thermal reaction and gold 
activation was not required.71 
 
2.2.4 Conclusion 
 
In conclusion, with the silver-free gold catalyst, the selective [2+2] cycloaddition was 
achieved with high efficiency under mild conditions (ambient temperature, open flask). 
Although the minor isomers were obtained, the fact that only two isolatable cyclobutane 
isomers were obtained highlighted the good selectivity and high efficiency of this 
transformation. The silver-free condition was identified as the crucial factor for the 
success of this transformation. The strong influence of silver salts (even in catalytic 
amounts) raised a viable concern for future investigations on gold catalysis, especially 
when an oxophilic catalyst may be involved. 
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2.2.5 Contribution 
 
Dr. Yijin Su and Yanwei Zhang were the researchers who had first investigated the 
reaction kinetic profile. Together Dr Jijin Su, and Yanwei Zhang were responsible for the 
[2+2] complexes synthesis, NMR spectrum investigation and manuscript completion for 
successful submission to Organic Letters. The detailed X-ray crystallographic data 
analysis of compound 2-2-3a and 2-2-3c’ was done by Prof. Jeffrey L. Petersen, C. 
Eugene Bennett Department of Chemistry, West Virginia University. 
  
55 
 
Chapter Three: Synthesis and characterization of bis-N-2-aryl 
triazole as efficient fluorescence probe  
3.1 Introduction 
 
Small organic molecules providing strong fluorescence emission are of great 
importance to the scientific community.72  These molecular fluorophores have been 
applied into a wide range of research areas, including chemistry, biology and material 
science.73 In 2009, Professor Clement Sanchez and co-workers discovered a novel 
photoactive crystalline highly porous titanium (IV) dicarboxylate. In the year of 2010, 
Professor Martin Albrecht and co-workers reported that N-heterocyclic carbene 
complexes worked not only as catalysts but also components in medicinal, luminescent, 
and functional material areas. 74-76 
Two notable aspects influence the efficiency of fluorescence: 1) quantum yield, and 
2) the wavelengths of excitation and emission. 
In 2011, Shi’s group reported N-2-aryl-1,2,3-triazoles (NAT) as novel fluorophores 
with strong emission in the high-energy UV/blue region.77 The first interest was initiated 
by the attractive phenomenon that in the N-1 phenyl triazole 3.1, basically no emission 
was observed while the N-2 isomer exhibited a relatively strong fluorescence emission 
(λ = 362 nm) under the identical excitation wavelength (λ = 254 nm) (Scheme 33).  
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Scheme 33. Photoluminescent Spectra of N-2-aryl-1,2,3-triazoles 
 
 
 
 
 
 
Sample preparation: 1.0×10−5 mol L−1 in MeOH, excitation at λ = 254 nm with 5 nm slit, quantum 
yield of 3.1 Φ = 0.154, quantum yield of 3.2 Φ = 0.009. 
 
Based on this result, it is suggested that, the fluorescence is presumably resulted 
from the coplanar conformation between the phenyl ring and the benzotriazole in the N-
2-aryl-triazoles (NATs). Therefore, we decided to implement the NATs complexes as 
effective fluorophores in further fluorescence study based on their fluorescence 
properties. As a result, a series of new N-2-aryl-triazoles (NATs) were synthesized and 
characterized (Scheme 34). 
Scheme 34. Synthesis of N-2-aryl-triazoles (NATs) 
 
 Three different effects are discussed in this NATs fluorescence investigation. The 
first investigation is the substituent effect on the C-4 and C-5 positions. Different 
 
3.1 
3.2 
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substituted groups were introduced to the C-4 and C-5 positions in the NATs. As 
discussed previously, the fluorescence emission is possibly resulted from the coplanar 
structure of the NATs. It was plausible that C-4 and C-5 substitution may influence the 
fluorescence emission through the conjugation of the entire NAT molecule. Moreover, 
all of these substrates presented strong emission in the UV/blue-light range with λmax at 
approximately 350 nm. 
Scheme 35. Fluorescence Emission Behavior of Compounds with Different C-5 
Substituents 
 
The second investigation was focused on the N-2 position substitution. Because the 
fluorescence was generated from the coplanar structure, we hypothesized that the 
variation of substituted group on N-2 position could have a significant influence on 
fluorescence emission.  
Scheme 36. Substituted Group Effect on the N-2 Position 
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Subsequent to synthesis of the above NATs (Scheme 36), the subsequent 
fluorescence study indicated that most compounds had good fluorescence emission 
and the overall quantum yield for these NATs is approximately 30 %. This result 
consequently confirmed the application potential of NATs as fluorophores in further 
research.  
Meanwhile, the crystal structures of 3.13 and 3.14 revealed the importance of 
coplanar structure in the generation of fluorescence. As shown in Scheme 37, due to 
the electron repulsion between the lone pair elections of the nitrogen atoms on both 
triazole and pyridine rings, the dihedral angle between the triazole ring and N-2 
substituted group in 3.14 (17.9o) was much larger than in 3.13 (5.4o). As a result, the 
coplanar conjugation of 3.14 was relatively weaker than 3.13. Therefore, 3.14 presented 
almost no emission but 3.13 presented a relatively strong emission. This result was 
sufficient to support the hypothesis that the coplanar structure was the key point in the 
process of generating intense fluorescence emission in the NATs types of compounds. 
Scheme 37. X-ray Crystal Structures of 3.13 and 3.14 
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The last investigation here concerns the substituted groups on N-2 substituted 
aromatic ring. Based on various electronic effects introduced by substituted groups (-Cl, 
-CN, -OMe), the fluorescence intensity and the emission wavelength can be tuned to a 
considerable degree. 
From all these above results, the NATs compounds have been demonstrated as a 
type of potential fluorophore in multiple research areas. Furthermore, we concluded that 
the strong fluorescence emission of NATs compounds is resulted from the coplanar 
conjugation between the triazole ring and N-2 substituted aromatic ring. 
Given a molecule in the excited state, there are basically two intramolecular charge 
transfer types: PICT (planar intramolecular charge transfer) and TICT (twisted 
intramolecular charge transfer). When the D-A (donor-acceptor) type chromophore 
forms the flat pattern, PICT state will be the major source for generation of fluorescence 
emission, whereas the twisted pattern will lead to the TICT state. Several typical model 
molecules have been introduced into the study of the PICT and TICT states.78 
Scheme 38. PICT and TICT in Fluorescence Emission 
 
As introduced, the generation of fluorescence emission for the NATs developed by 
Shi’s group is generated by the PICT. However in other reported molecules, the TICT is 
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the dominate mechanism for fluorescence emission. When the electron donor (D) 
/acceptor (A) subgroups form a mutually perpendicular configuration, the TICT excited 
state will dominate.  
 
3.2 Synthesis and characterization of naphthalene-bridged bis-N-2-aryl triazoles 
(NBTs) as efficient fluorescence probe through twisted intramolecular charge 
transfer mechanism 
To investigate the difference of PICT and TICT, as well as discover a new 
fluorophore based on TICT mechanism, naphthalene-bridged bis-N-2-aryl triazoles 
(NBTs) compounds were prepared and applied in the fluorescence study. 
As mentioned, the PICT mechanism (observed in N-2 isomers, Scheme 39A) 
contributed the effective fluorescence emission in NATs compounds. Herein, we 
reported the design and synthesis of NBT compounds, which gave excellent 
fluorescence emission, even with a twisted conformation between triazole and N-2 aryl 
groups (Scheme 39B), suggesting the twisted intramolecular charge transfer (TICT) as 
the plausible mechanism for the observed strong fluorescence emission.79 
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Scheme 39. N-2-aryl Triazole Fluorophores 
 
 
Previously, we reported that N-2-aryl triazole 3.1 gave very strong fluorescence 
emission while its N-1 isomer 3.2 gave no emission at all. Two key factors appeared to 
control the fluorescence emission in these NAT dyes: N-2 substitution and coplanar 
conformation between the two rings. However, the second assumption was greatly 
questioned by our recent studies of N-naphthalene triazoles.  As shown in Scheme 40, 
we prepared phenyl triazole 3-1a (N-2 isomer) and 3-1b (N-1 isomer); N-naphthalene 
triazole 3-1c (N-2 isomer) and 3-1d (N-1 isomer).  Similar to benzyl triazoles, the N-1 
isomer 3-1b and 3-1d gave no fluorescence emission and N-2 isomer 3-1a and 3-1c 
gave strong emission.  However, a closer look of 3-1c suggests that coplanar 
conformation between naphthalene and triazole ring is highly unlikely due to the steric 
repulsion.  In fact, in our previous research, we found the crystal structure of a similar 
analog to 3-1c indicated a 49.5o dihedral angle between the naphthalene ring and 
triazole ring.80  These results initiated our interest in further exploring this new class of 
fluorescent dyes with the question whether the coplanar conformation is necessary.81  
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Scheme 40. Fluorescence Emission of NAT with Different Aryl Groups 
 
Besides the coplanar intramolecular charge transfer (PICT), another feasible 
photochemical process associated with this type of extended aromatic ring—i.e., the 
twisted intramolecular charge transfer (TICT)--was first introduced by Grabowski et al.82 
One important feature of TICT type of emission is the feasibility of the donor unit in 
initiating the charge transfer.  Numerous nitrogen containing heterocycles have been 
studied as donors in TICT emitting molecules.83 However, to the best of our knowledge 
1,2,3-triazoles have not been used as a potential donor in the TICT fluorophores and 
their photochemical properties remain unknown. 
To explore triazole derivatives as potential TICT emitting dyes, we prepared 
anthracene substituted triazole 3-1e (N-2) and 3-1f (N-1).  Clearly, the anthracene 
should provide a large steric repulsion that can prevent the formation of coplanar 
conformation even in the N-2 isomer 3-1e.  Thus the fluorescence emission should be 
mainly from the twisted state.  Interestingly, both N-1 and N-2 isomers gave good 
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emission.  However, three different emission bands were observed in the N-1 isomer 3-
1f, which was similar to the typical emission of aromatic substituted anthracene.84  This 
result suggested that triazole-anthracene compounds were not good model molecules 
to evaluate the triazole’s influence on TICT emission due to the notable background 
emission from anthracene.  To better evaluate the triazole influence in the twisted 
systems, we designed the naphthalene-bridged bis-triazole (NBT).   
Scheme 41. Synthesis of Naphthalene-bridged Bis-triazoles (NBTs) 
 
As shown in Scheme 41, the bis-triazole can be readily prepared from the copper 
catalyzed coupling between naphthalene di-iodide 3-2b and NH-triazole.  Two different 
conditions were developed to reach NBT, either in a one-pot fashion (Condition A) or 
stepwise process (Condition B). With the use of these methods, both symmetrical NBT 
3-3 and asymmetrical NBT 3-5 could be easily prepared. Notably, both N-1 and N-2 
isomers were observed in all cases.  The regioselectivity (ratio between N-2 and N-1 
isomers) depends on the substituted groups (Ar), similar to what has been observed 
previously in triazoles functionalization.85 The N-1 and N-2 isomers could be easily 
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separated using column chromatography due to the significant polarity difference.  
Perhaps, the most important question for the synthesis of NBT was how to identify the 
relative position of the two triazole rings with restricted rotation. Considering the rotation 
of C-N bonds, theoretically two conformers (cis and trans) could be formed.  
Interestingly, during our synthesis, only one conformer was observed in nearly all cases, 
which was later confirmed to be the cis-conformer via X-ray crystallography (Scheme 
42). 
 Scheme 42. X-ray Crystallography Confirmed the Formation of Cis-conformer 
 
As shown in the X-ray crystal structure, the twisted conformation was 
confirmed between triazole and naphthalene rings with a dihedral angle of 61.5o.  
The crystal structure of mono-triazole substituted 3-4a (Ar1 = Ph, with I on 
naphthalene ring) was also obtained.  Similarly, the dihedral angle observed for 3-4a 
between these two rings is 62.9o.  With all clearly characterized NBTs, their fluorescent 
properties were measured and shown in Scheme 43. 
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Scheme 43. Fluorescence Emission of NBT 3-3 and 3-4a 
 
As shown by the solid-state crystal structures, both bis-triazole NBT 3-3 and mono-
triazole 3-4 adopted a twisted conformation.  However, while N-2 isomers generally 
gave good fluorescence emission, the N-1 isomers gave almost no emission in all cases.  
The emission intensity of NBT 3-3 followed a clear trend of N2-N2 > N2-N1 > N1-N1 
(almost no emission).  Due to the rotation strain, it is impossible for NBT 3-3 to adopt a 
planar conformation even in solution.  Thus the observed good fluorescence emission of 
the N-2 isomers likely represents the photochemical process associated TICT states.  
The optical properties (emission, excitation and quantum yields) of compounds 3-3 and 
3-4 were determined and summarized in Table 9. 
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Table 9. Comparison of Optical Properties of Different NBTs a 
 R
1
/R
2
 excitation emission Φ Stokes shift 
       NAT 
3-1a - 298 347 0.34 49 
3-4a N2-TA-I 300 378 0.20 78 
       NBT 
3-3a R
1
=R
2
=H (N1-N1) - - <0.01 - 
3-3b R
1
=R
2
=H (N1-N2) 307 384 0.13 77 
3-3c R
1
=R
2
=H (N2-N2) 315 393 0.24 78 
3-5a R
1
=R
2
=Cl 305 393 0.26 88 
3-5b R
1
=R
2
=OMe 315 403 0.29 88 
3-5c R
1
=R
2
=COOMe 300 396 0.41 96 
3-5d R
1
=R
2
=CN 302 403 0.47 101 
3-5e R
1
=OMe, R
2
=CN 300 408 0.39 108 
aSample information: 1.0 x 10-6 mol/L in dichloromethane; Quantum yields (Φ) were determined 
based on 1.0 x 10-6 mol/L 9,10-diphenylanthracene in cyclohexane (Φ = 0.9); Calculated photo 
emission integration from the original spectra.  All fluorescence data are measured under 
identical conditions.  
 
While these N-2 isomers of NBTs were identified as a new class of fluorophores, one 
interesting feature offered by the naphthalene-bridge was the potential for π-π stacking 
between the two triazoles.86 As revealed by the structural analysis of 3-3c, the two 
triazoles in NBT are nearly parallel, with the distance just slightly longer than the sum of 
the van der Waals radii. Thus, it is reasonable to expect that the substituted groups on 
the triazole phenyl ring may provide various electronic effects that will influence the 
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overall optical properties 87 In order to explore the substituted group influence, a series 
of symmetrical and asymmetrical NBT 3-5 were prepared with various substituents on 
the triazole phenyl rings.  Their photochemical properties were evaluated (Table 9), and 
the fluorescence spectra of some representative NBTs are shown in Scheme 44. 
Among all the tested NBTs, the N-2 substitution is crucial for effective 
emission.  Compared with previous planar NAT 3-1a, the new twisted NBT 
fluorophores gave more red shift emissions approximately 400 nm (blue light).  
Interestingly, although the two triazole rings are nearly parallel, changing the 
substituent groups on phenyl rings did not influence the overall emission of the 
NBT.  For example, with either EDG (3-5b) or EWG (3-5c and 3-5d) substituted 
NBT; there were few changes on the emission and excitation wavelengths.  
Furthermore, substrate 3-5e with EDG and EWG incorporated on different rings 
also gave similar emission, which strongly suggested that minimal π-π 
interactions occurred between the two rings.  Notably, the substitute groups did 
help to improve the quantum yields (up to 47 %) through the introduction of 
extended conjugations.88 Overall, in comparison with NAT, this new NBT system 
gave significantly higher fluorescence efficiency, which implied great potential for 
future applications. 
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Scheme 44. Fluorescence Emission of NBT 3-5 and 3-4a 
 
 
3.3 Conclusion 
In conclusion, we herewith report a new type of triazole based fluorescence-active 
compounds: naphthalene-bridged bis-triazole (NBT).  Practical syntheses have been 
developed and regio-isomers of compounds were characterized by X-ray 
crystallography.  The fluorescence studies reveal that in this twisted system, the N-2 
substitution is crucial for effective fluorescence emission.  Comparing with previously 
reported NAT system, this new NBT gave higher fluorescence efficiency and larger 
Stokes shifts, which warrants the potential as new molecule probes for chemical and 
biological applications. 
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3.4 Contribution 
Yanwei Zhang was the researcher who had first investigated the reaction condition 
and fluorescence property. Together, Yanwei Zhang and Xiaohan Ye were responsible 
for substrate scope, NMR spectrum, fluorescence data and manuscript completion for 
successful submission to Journal of Organic Chemistry. The detailed X-ray 
crystallographic data analysis of compound 3-3c was done by Prof. Jeffrey L. Petersen, 
C. Eugene Bennett Department of Chemistry, West Virginia University. 
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Supporting Information 
 
Chapter One: Triazole-Au(I) complex as chemoselective catalyst in promoting 
propargyl ester rearrangements. 
 
I. General methods and materials 
 
All of the reactions dealing with air and/or moisture-sensitive react were carried out 
under an atmosphere of nitrogen using oven/flame-dried glassware and standard 
syringe/septa techniques. Unless otherwise noted, all commercial reagents and 
solvents were obtained from a commercial provider and used without further purification. 
1H NMR and 13C NMR spectra were recorded on Varian 600 MHz spectrometers. 
Chemical shifts were reported relative to internal tetramethylsilane (δ 0.00 ppm) or 
CDCl3 (δ 7.26 ppm) for 
1H NMR and CDCl3 (δ 77.0 ppm) for 
13C NMR. Flash column 
chromatography was performed on 230–430 mesh silica gel. Analytical thin layer 
chromatography was performed with precoated glass baked plates (250μ) and 
visualized by fluorescence and by charring after treatment with potassium 
permanganate stain. HRMS were recorded on LTQ-FTUHRA spectrometer. 
Substrates 1-1, 1-5 were synthesized according to the literatures as below: 
1. Hashmi, A. S. K.; Rudolph, M. Chem. Soc. Rev. 2008, 37, 1766–1775. 
2. Gorin, D. J.; Sherry, B. D.; Toste, F. D. Chem. Rev. 2008, 108, 
3. Arcadi, A. Chem. Rev. 2008, 108, 3266–3325. 
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Representative procedure for the preparation of allene 1-2a 
  
 
To a solution of 1-1a (58 mg, 0.25 mmol) in dry CH2Cl2 (2.5 mL, 0.1 M), was added 
Au(I) catalyst (1.9 mg, 0.0025 mol, 1.0 mol %) at RT. The reaction mixture was stirred at 
RT and monitored by TLC. After the reaction was completed (2–10 h), the solvent was 
removed under reduced pressure and the residue was purified by flash chromatography 
on silica gel (ethyl acetate/hexane = 1 : 20, v/v) to give 1-2a (91% yield) as colorless oil. 
II. Compounds characterization 
 
1-Phenylhepta-1,2-dien-3-yl acetate (1-2a): 91% yield, 1H NMR (600 MHz, CDCl3): δ 
7.43-7.44 (m, 2H), 7.32-7.35 (m, 2H), 7.25-7.27 (m, 1H), 6.59 (t, J = 3.0 Hz, 1H), 2.33-
2.37 (m, 2H), 2.15 (s, 3H), 1.46-1.51 (m, 2H), 1.38-1.43 (m, 2H), 0.90 (t, J = 7.2 Hz, 3H); 
13C NMR (150 MHz, CDCl3): δ 196.7, 168.6, 133.9, 129.2, 128.6, 127.9, 127.0, 104.5, 
31.5, 28.3, 22.1, 21.0, 13.8. 
 
1-p-Tolylhepta-1,2-dien-3-yl acetate (1-2b): 90% yield, 1H NMR (600 MHz, CDCl3): δ 
7.32 (d, J = 8.4 Hz, 2H), 7.13 (d, J = 7.8 Hz, 2H), 6.56 (t, J = 3.0 Hz, 1H), 2.31-2.35 (m, 
2H), 2.33 (s, 3H), 2.13 (s, 3H), 1.45-1.48 (m, 2H), 1.34-1.40 (m, 2H), 0.89 (t, J = 7.2 Hz, 
3H); 13C NMR (150 MHz, CDCl3): δ 196.1, 168.6, 137.9, 131.0, 129.3, 127.7, 126.7, 
104.4, 31.5, 28.3, 22.1, 21.2, 21.0, 13.8. 
 
 
1-(4-Fluorophenyl)hepta-1,2-dien-3-yl acetate (1-2c): 87% yield, 1H NMR (600 MHz, 
CDCl3): δ 7.39-7.41 (m, 2H), 7.00-7.03 (m, 2H), 6.55 (t, J = 3.0 Hz, 1H), 2.31-2.35 (m, 
2H), 2.15 (s, 3H), 1.44-1.49 (m, 2H), 1.36-1.41 (m, 2H), 0.90 (t, J = 7.2 Hz, 3H). 13C 
NMR (150 MHz, CDCl3): δ 196.4, 168.6, 161.8 (d, J = 246.5 Hz), 130.0 (d, J = 3.2 Hz), 
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129.4 (d, J = 8.3 Hz), 126.9, 115.5 (d, J = 21.9 Hz), 103.4 (d, J = 2.7 Hz), 31.5, 28.3, 
22.1, 21.0, 13.8. 
 
 
1-(4-Methoxyphenyl)hepta-1,2-dien-3-yl acetate (1-2d): 89% yield, 1H NMR (600 MHz, 
CDCl3): δ 7.36 (d, J = 8.4 Hz, 2H), 6.87 (d, J = 9.0 Hz, 2H), 6.54 (t, J = 3.0 Hz, 1H), 3.81 
(s, 3H), 2.28-2.34 (m, 2H), 2.14 (s, 3H), 1.44-1.47 (m, 2H), 1.35-1.39 (m, 2H), 0.90 (t, J 
= 7.2 Hz, 3H). 13C NMR (150 MHz, CDCl3): δ 195.3, 168.8, 159.6, 129.0, 126.6, 126.4, 
114.2, 104.0, 55.3, 31.6, 28.4, 22.1, 21.1, 13.8. 
 
 
1-(4-Nitrophenyl)hepta-1,2-dien-3-yl acetate (1-2e): 89% yield, 1H NMR (600 MHz, 
CDCl3): δ 8.18-8.20 (m, 2H), 7.56-7.58 (m, 2H), 6.63 (t, J = 3.0 Hz, 1H), 2.34-2.37 (m, 
2H), 2.17 (s, 3H), 1.45-1.55 (m, 2H), 1.37-1.41 (m, 2H), 0.91 (t, J = 7.2 Hz, 3H). 13C 
NMR (150 MHz, CDCl3): δ 200.2, 168.2, 147.2, 140.9, 128.3, 127.5, 124.0, 102.6, 31.4, 
28.2, 22.1, 22.0, 13.8. HRMS Calculated for [C15H17NO4+Na]+: 298.1050, Found: 
298.1050. 
 
 
1-Cyclopropyl-3-phenylpropa-1,2-dienyl acetate (1-2f): 85% yield, 1H NMR (600 MHz, 
CDCl3): δ 7.39-7.40 (m, 2H), 7.31-7.33 (m, 2H), 7.23-7.24 (m, 1H), 6.59 (d, J = 2.4 Hz, 
1H), 2.16 (s, 3H), 1.55-1.59 (m, 1H), 0.77-0.80 (m, 2H), 0.59-0.65(m, 2H). 13C NMR 
(150 MHz, CDCl3): δ 196.4, 168.6, 133.7, 128.7, 128.1, 127.8, 105.1, 93.0, 20.9, 11.9, 
6.4, 5.9. HRMS Calculated for [C14H14O2+H]+: 215.1066, Found: 215.1059. 
 
 
Ethyl 1-phenylhepta-1,2-dien-3-yl carbonate (1-5a): 92% yield, 1H NMR (600 MHz, 
CDCl3): δ 7.42-7.43 (m, 2H), 7.32-7.35 (m, 2H), 7.24-7.27 (m, 1H), 6.65 (t, J = 3.0 Hz, 
1H), 4.24 (q, J = 7.2 Hz, 2H), 2.37-2.41 (m, 2H), 1.47-1.51 (m, 2H), 1.37-1.41 (m, 2H), 
1.32 (t, J = 7.2 Hz, 3H), 0.89 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 196.4, 
153.1, 133.7, 128.7, 128.3, 128.1, 127.9, 105.7, 64.5, 31.3, 28.2, 22.1, 14.2, 13.8. 
HRMS Calculated for [C16H20O3+Na]+: 283.1305, Found: 283.1305. 
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t-Butyl 1-phenylhepta-1,2-dien-3-yl carbonate (1-5b): 91% yield, 1H NMR (600 MHz, 
CDCl3): δ 7.41-7.42 (m, 2H), 7.31-7.34 (m, 2H), 7.23-7.26 (m, 1H), 6.63 (t, J = 3.0 Hz, 
1H), 2.35-2.39 (m, 2H), 1.50 (s, 9H), 1.46-1.48 (m, 2H), 1.37-1.41 (m, 2H), 0.89 (t, J = 
7.5 Hz, 3H). 13C NMR (150 MHz, CDCl3): δ 196.7, 151.2, 134.0, 128.6, 128.1, 128.0, 
127.8, 105.2, 82.9, 31.4, 28.3, 27.9, 22.1, 13.8. HRMS Calculated for [C18H24O3+Na]+: 
311.1618, Found: 311.1604. 
 
 
Allyl 1-phenylhepta-1,2-dien-3-yl carbonate (1-5c): 88% yield, 1H NMR (600 MHz, 
CDCl3): δ 7.41 (d, J = 7.8 Hz, 2H), 7.33 (t, J = 7.5 Hz, 2H), 7.24-7.27 (m, 1H), 6.65 (s, 
1H), 5.91-5.97 (m, 1H), 5.35 (d, J = 17.4 Hz, 1H), 5.26 (d, J = 10.2 Hz, 1H), 4.65 (d, J = 
6.0 Hz, 2H), 2.30-2.34 (m, 2H), 1.47-1.53 (m, 2H), 1.36-1.43 (m, 2H), 0.89 (t, J = 6.9 Hz, 
3H). 13C NMR (150 MHz, CDCl3): δ 196.3, 152.9, 133.7, 131.3, 128.7, 128.4, 128.1, 
127.9, 119.2, 105.8, 68.9, 31.3, 28.2, 22.1, 13.8. HRMS Calculated for 
[C17H20O3+Na]+: 295.1305, Found: 295.1306. 
 
 
Ethyl 1-(3-nitrophenyl)hepta-1,2-dien-3-yl carbonate (1-5d): 92% yield, 1H NMR (600 
MHz, CDCl3): δ 8.25-8.26 (m, 1H), 8.09-8.12 (m, 1H), 7.77-7.78 (m, 1H), 7.51 (t, J = 8.1 
Hz, 1H), 6.70 (t, J = 3.0 Hz, 1H), 4.24 (q, J = 7.4 Hz, 1H), 2.39-2.43 (m, 2H), 1.48-1.56 
(m, 2H), 1.39-1.44 (m, 2H), 1.33 (t, J = 8.1 Hz, 3H), 0.91 (t, J = 7.2 Hz, 3H). 13C NMR 
(150 MHz, CDCl3): δ 198.3, 152.7, 148.7, 135.9, 133.4, 129.5, 129.2, 122.7, 122.5, 
103.6, 64.8, 31.3, 28.1, 22.1, 14.2, 13.7. HRMS Calculated for [C16H19NO5+Na]+: 
328.1155, Found: 328.1142. 
 
 
t-Butyl 1-(3-nitrophenyl)hepta-1,2-dien-3-yl carbonate (1-5e): 89% yield, 1H NMR 
(600 MHz, CDCl3): δ 8.23-8.24 (m, 1H), 8.09-8.11 (m, 1H), 7.77 (dt, J = 7.8 Hz, 1.2 Hz, 
1H), 7.50 (t, J = 8.1 Hz, 1H), 6.68 (t, J = 3.0 Hz, 1H), 2.37-2.41 (m, 2H), 1.51 (s, 9H), 
1.47- 1.50 (m, 2H), 1.38-1.42 (m, 2H), 0.90 (t, J = 7.2 Hz, 3H). 13C NMR (150 MHz, 
CDCl3): δ 198.6, 150.8, 148.7, 136.2, 133.4, 129.5, 128.9, 122.5, 122.4, 103.2, 83.4, 
31.4, 28.2, 27.7, 22.1, 13.8. HRMS Calculated for [C18H23NO5+Na]+: 356.1468, 
Found: 356.1454. 
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1-(3-Nitrophenyl)hepta-1,2-dien-3-yl diphenylcarbamate (1-5f): 85% yield, 1H NMR 
(600 MHz, CDCl3): δ 8.22 (t, J = 2.1 Hz, 1H), 8.07 (dq, J = 8.4 Hz, 1.0 Hz, 1H), 7.77 (dt, 
J = 7.8 Hz, 1.2 Hz, 1H), 7.48 (t, J = 7.8 Hz, 1H), 7.34 (t, J = 7.8 Hz, 4H), 7.21-7.28 (m, 
6H), 6.65 (t, J = 3.0 Hz, 1H), 2.30-2.34 (m, 2H), 1.31-1.41 (m, 4H), 0.85 (t, J = 7.2 Hz, 
3H). 13C NMR (150 MHz, CDCl3): δ 198.7, 152.0, 148.6, 142.2, 136.4, 133.5, 129.5, 
128.9, 128.3, 126.8, 126.4, 122.4, 122.3, 102.8, 31.6, 28.1, 21.9, 13.7. HRMS 
Calculated for [C26H24N2O4+Na]+: 451.1628, Found: 451.1610 
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III. NMR spectra  
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Chapter Two: Further transformations from allene intermediate formed by 
Triazole-Au(I) complex as promoting propargyl ester rearrangements. 
2.1 Triazole gold promoted, effective synthesis of enonoes from prypargylic 
esters and alcohols 
I. General methods and materials 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out 
under an atmosphere of nitrogen using oven/flame-dried glassware and standard 
syringe/septa techniques. Unless otherwise noted, all commercial reagents and 
solvents were obtained from the commercial provider and used without further 
purification. 1H NMR and 13C NMR spectra were recorded on Varian 600 MHz 
spectrometers. Chemical shifts were reported relative to internal tetramethylsilane (δ 
0.00 ppm) or CDCl3 (δ 7.26 ppm) for 1H NMR and CDCl3 (δ 77.0 ppm) for 13C NMR. Flash 
column chromatography was performed on 230-430 mesh silica gel. Analytical thin layer 
chromatography was performed with precoated glass baked plates (250μ) and 
visualized by fluorescence and by charring after treatment with potassium 
permanganate stain. HRMS were recorded on LTQ-FTUHRA spectrometer. 
Substrates 2-1-1 and 2-1-5 were synthesized according to the literature as below: 
1. M. Yu, G. Zhang, L. Zhang, Org. Lett. 2007, 9, 2147-2150. 
2. N. Marion, P. Carlqvist, R. Gealageas, P. Fremont, F. Maseras, S. P. Nolan, Chem. 
Eur. J. 2007, 13, 6437-6451. 
Representative procedure for the preparation of α,ß-unsatured ketone 2-1-4a 
To a solution of 2-1-1a (288 mg, 1.25 mmol) in wet MeOH (5 mL, 0.25 M, MeOH:H2O = 
100:1), was added Au(I) catalyst (1.8 mg, 0.0025 mol, 0.2 mol%) at 60 oC. The reaction 
mixture was stirred at 60 oC and monitored by TLC. After the reaction was completed (4 
h), the solvent was removed under reduced pressure and the residue was purified by 
flash chromatography on silica gel (ethyl acetate/hexane = 1 : 20, V/V) to give 2-1-4a 
(92% yield) as colorless oil. 
Representative procedure for the preparation of α,ß-unsatured ketone 2-1-4a from 
2-1-5a 
To a solution of 2-1-5a (94 mg, 0.5 mmol) in wet MeOH (2.5 mL, MeOH:H2O = 100:1), 
was added Au(I) catalyst (1.8 mg, 0.0025 mol, 0.5 mol%) at 60 oC. The reaction mixture 
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was stirred at 60 oC and monitored by TLC. After the reaction was completed (3 h), the 
solvent was removed under reduced pressure and the residue was purified by flash 
chromatography on silica gel (ethyl acetate/hexane = 1 : 20, V/V) to give 2-1-4a (89% 
yield) as colorless oil. 
II. Compounds characterization 
 
(E)-1-phenylhept-1-en-3-one (E-2-1-4a): (Known compound, See: N. Marion, P. 
Carlqvist,. Gealageas, P. Fremont, F. Maseras, S. P. Nolan, Chem. Eur. J. 2007, 13, 
6437-6451) 1H NMR (600 MHz, CDCl3): δ 7.53-7.56 (m, 3H), 7.38-7.40 (m, 3H), 6.73 (t, 
J = 16.2 Hz, 1H), 2.66 (t, J = 7.5 Hz, 2H), 1.66 (quintet, J = 7.5 Hz, 2H), 1.37 (sextet, J = 
7.4 Hz, 2H), 0.94 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 200.8, 142.5, 134.8, 
130.6, 129.1, 128.4, 126.5, 40.9, 26.7, 22.7, 14.1. 
 
(E)-4,4-dimethyl-1-phenylpent-1-en-3-one (E-2-1-4b): (Known compound, See: R. S. 
Ramon, S. Gaillard, A. M. Z. Slawin, A. Porta, A. D'Alfonso, G. Zanoni, S. P. Nolan, 
Organometallics 2010, 29, 3665-3668) 1H NMR (600 MHz, CDCl3): δ 7.69 (d, J = 16.2 
Hz, 1H, E), 7.56-7.58 (m, 2H, E), 7.53-7.54 (m, 2H, Z), 7.37-7.40 (m, 3H, E), 7.29-7.33 
(m, 3H, Z), 7.13 (d, J = 15.6 Hz, 1H, E), 6.78 (d, J = 13.0 Hz, 1H, Z), 6.45 (d, J = 13.0 
Hz, 1H, Z), 1.23 (s, 9H, E), 1.20 (s, 9H, Z). 13C NMR (150 MHz, CDCl3): δ 204.2, 142.9, 
140.1, 134.9, 130.2, 129.5, 128.8, 128.3, 128.1, 124.3, 120.8, 43.2, 26.3, 26.2 (Z+E). 
 
(E)-dec-6-en-5-one (E-2-1-4c): (Known compound, See: M. N. Pennell, M. G. Unthank, 
P. Turner, T. D. Sheppard, J. Org. Chem. 2011, 76, 1479-1482) 1H NMR (600 MHz, 
CDCl3): δ 6.82 (dt, J = 16.2, 6.6 Hz, 1H), 6.10 (dt, J = 15.6, 3.6 Hz, 1H), 2.53 (t, J = 7.8 
Hz, 2H), 2.20 (qd, J = 7.2, 1.2 Hz, 2H), 1.60 (quintet, J = 7.7 Hz, 2H), 1.50 (sextet, J = 
7.4 Hz, 2H), 1.34 (sextet, J = 7.4 Hz, 2H), 0.95 (t, J = 7.2 Hz, 3H), 0.92 (t, J = 7.2 Hz, 
3H); 13C NMR (150 MHz, CDCl3): δ 200.9, 146.9, 130.5, 39.8, 34.4, 26.4, 22.4, 21.3, 
13.8, 13.6. 
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(E)-1-p-tolylhept-1-en-3-one (E-2-1-4d): (Known compound, See: N. Marion, P. 
Carlqvist, R. Gealageas, P. Fremont, F. Maseras, S. P. Nolan, Chem. Eur. J. 2007, 13, 
6437-6451) 1H NMR (600 MHz, CDCl3): δ 7.51 (d, J = 16.2, Hz, 1H), 7.43 (d, J = 7.8 Hz, 
2H), 7.19 (d, J = 8.4 Hz, 2H), 6.71 (d, J = 15.6 Hz, 1H), 2.64 (t, J = 7.5 Hz, 2H), 2.37 (s, 
3H), 1.66 (quintet, J = 7.7 Hz, 2H), 1.37 (sextet, J = 7.4 Hz, 2H), 0.92 (t, J = 7.5 Hz, 3H); 
13C NMR (150 MHz, CDCl3): δ. 200.6, 142.3, 140.8, 131.8, 129.6, 128.2, 125.3, 40.5, 
26.5, 22.4, 21.4, 13.8. 
 
(E)-1-cyclopropyl-3-phenylprop-2-en-1-one (E-2-1-4e): (Known compound, See: G. V. 
Kryshtal, G. M. Zhdankina, S. G. Zlotin, Eur. J. Org. Chem. 2005, 13, 2822-2827) 1H 
NMR (600 MHz, CDCl3): δ 7.63 (d, J = 16.2 Hz, 1H), δ 7.55-7.57 (m, 2H), 7.38-7.40 (m, 
3H), 6.86 (d, J = 16.2 Hz, 1H), 2.22-2.27 (m, 1H), 1.15-1.17 (m, 2H), 0.95-0.99 (m, 2H); 
13C NMR (150 MHz, CDCl3): δ 199.9, 141.9, 134.6, 130.2, 128.8, 128.2, 126.4, 19.6, 
11.3. 
 
(Z)-1-cyclopropyl-3-phenylprop-2-en-1-one (Z-2-1-4e): (Known compound, See: 
Kryshtal, G. M. Zhdankina, S. G. Zlotin, Eur. J. Org. Chem. 2005, 13, 2822-2827) 1H 
NMR (600 MHz, CDCl3): δ 7.49-7.51 (m, 2H), 7.32-7.35 (m, 3H), 6.93 (d, J = 12.6 Hz, 
1H), 6.24 (d, J = 12.6 Hz, 1H), 1.88-1.92 (m, 1H), 1.10-1.13 (m, 2H), 0.81-0.83 (m, 2H); 
13C NMR (150 MHz, CDCl3): δ 203.7, 139.3, 135.4, 129.6, 129.5, 128.9, 128.1, 22.1, 
12.5. 
 
(E)-1-phenylhex-2-en-1-one (E-2-1-4f): (Known compound, See: N. Marion, P. 
Carlqvist, R. Gealageas, P. Fremont, F. Maseras, S. P. Nolan, Chem. Eur. J. 2007, 13, 
6437-6451) 1H NMR (600 MHz, CDCl3): δ 7.91-7.93 (m, 2H), 7.52-7.54 (m, 1H), 7.45 (t, 
J = 7.5 Hz, 2H), 7.05 (dt, J = 15.6, 7.8 Hz, 1H), 6.86 (dt, J = 15.0, 1.5 Hz, 1H), 2.28 (m, 
2H), 1.54 (sextet, J = 7.3 Hz, 2H), 0.97 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): 
δ 190.8, 149.6, 137.9, 132.4, 128.4, 128.3, 125.9, 34.7, 21.3, 13.6. 
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(E)-oct-2-en-4-one (E-2-1-4g): (Known compound, See: A. R. Katritzky, D. C. Oniciu, I. 
Ghiviriga, F. Soti, J. Org. Chem. 1998, 63, 2110-2115) 1H NMR (600 MHz, CDCl3): δ 
6.85 (dq, J = 16.2, 6.8 Hz, 1H), 6.11 (dq, J = 15.6, 1.6 Hz, 1H), 2.52 (t, J = 7.5 Hz, 2H), 
1.90 (dd, J = 6.6, 1.8 Hz, 3H), 1.59 (quintet, J = 7.5 Hz, 2H), 1.33 (sextet, J = 7.6 Hz, 
2H), 0.91 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 200.7, 142.2, 131.9, 39.8, 
26.4, 22.4, 18.2, 13.8. 
 
(E)-1-(4-fluorophenyl)hept-1-en-3-one (E-2-1-4h): (Known compound, See: N. Marion, 
P. Carlqvist, R. Gealageas, P. Fremont, F. Maseras, S. P. Nolan, Chem. Eur. J. 2007, 
13, 6437-6451) 1H NMR (600 MHz, CDCl3): δ 7.50-7.54 (m, 3H), 7.08 (t, J = 8.4 Hz, 2H), 
6.66 (d, J = 16.2 Hz, 1H), 2.65 (t, J = 7.5 Hz, 2H), 1.66 (quintet, J = 7.4 Hz, 2H), 1.38 
(sextet, J = 7.5 Hz, 2H), 0.94 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 200.3, 
163.0 (d, J = 249.8 Hz), 140.8, 130.8 (d, J = 1.8 Hz), 130.0 (d, J = 8.3 Hz), 125.9, 116.0 
(d, J = 21.8 Hz), 40.7, 26.4, 22.3, 13.8. 
 
2-methyloct-2-en-4-one (2-1-4i): (Known compound, See: M. Yu, G. Li, S. Wang, L. 
Zhang, Adv. Synth. Catal. 2007, 349, 871-875) 1H NMR (600 MHz, CDCl3): δ 6.06-6.08 
(m, 1H), 2.40 (t, J = 7.5 Hz, 2H), 2.14 (d, J = 1.2 Hz, 3H), 1.88 (d, J = 1.2 Hz, 3H), 1.57 
(quintet, J = 7.5 Hz, 2H), 1.32 (sextet, J = 7.4 Hz, 2H), 0.91 (t, J = 7.2 Hz, 3H); 13C NMR 
(150 MHz, CDCl3): δ 201.2, 154.5, 123.8, 43.9, 27.5, 26.4, 22.4, 20.6, 13.8. 
 
(E)-2-methylnon-3-en-5-one (E-2-1-4j): (Known compound, See: M. Yu, G. Li, S. 
Wang, L. Zhang, Adv. Synth. Catal. 2007, 349, 871-875) 1H NMR (600 MHz, CDCl3): δ 
6.78 (dd, J = 16.2, 6.6 Hz, 1H), 6.03 (dd, J = 16.2, 1.8 Hz, 1H), 2.53 (t, J = 7.5 Hz, 2H), 
2.41-2.48 (m, 1H), 1.59 (quintet, J = 7.4 Hz, 2H), 1.32 (sextet, J = 7.4 Hz, 2H),1.07 (d, J 
= 6.6 Hz, 6H), 0.91 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 201.2, 153.1, 
127.5, 39.8, 31.0, 26.4, 22.4, 21.3, 13.8. 
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2-cyclohexylidene-1-phenylethanone (2-1-4k): (Known compound, See: B. Lu, C. Li, 
L. Zhang, J. Am. Chem. Soc. 2005, 127, 14180-14181) 1H NMR (600 MHz, CDCl3): δ 
7.93-7.95 (m, 2H), 7.51-7.54 (m, 1H), 7.43-7.46 (m, 2H), 6.60-6.61 (m, 1H), 2.76-2.78 
(m, 2H), 2.31 (td, J = 6.3, 0.6 Hz, 2H), 1.71-1.75 (m, 2H), 1.62-1.66 (m, 4H); 13C NMR 
(150 MHz, CDCl3): δ 192.3, 162.7, 139.3, 132.3, 128.4, 128.3, 118.7, 38.4, 30.6, 28.9, 
28.0, 26.3. 
 
(E)-1-(4-methoxyphenyl)hept-1-en-3-one (E-2-1-4l): (Known compound, See: N. 
Marion, P. Carlqvist, R. Gealageas, P. Fremont, F. Maseras, S. P. Nolan, Chem. Eur. J. 
2007, 13, 6437-6451) 1H NMR (600 MHz, CDCl3): δ 7.51 (d, J = 15.6 Hz, 1H), 7.49 (d, J 
= 8.4 Hz, 2H), 6.90 (d, J = 8.4 Hz, 2H), 6.63 (d, J = 16.2 Hz, 1H), 3.83 (s, 3H), 2.63 (t, J 
= 7.5 Hz, 2H), 1.66 (quintet, J = 7.5 Hz, 2H), 1.38 (sextet, J = 7.4 Hz, 2H), 0.94 (t, J = 
7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 200.6, 161.5, 142.0, 129.9, 127.2, 124.1, 
114.3, 55.3, 40.5, 26.6, 22.4, 13.9. 
 
(E)-chalcone (E-2-1-4m): (Known compound, See: N. Marion, P. Carlqvist, R. 
Gealageas, P. Fremont, F. Maseras, S. P. Nolan, Chem. Eur. J. 2007, 13, 6437-6451) 
1H NMR (600 MHz, CDCl3): δ 8.00-8.02 (m, 2H), 7.80 (d, J = 15.6 Hz, 1H), 7.62-7.63 (m, 
2H), 7.55-7.58 (m, 1H), 7.52 (d, J = 15.6 Hz, 1H), 7.49 (t, J = 7.5 Hz, 2H), 7.38-7.41 (m, 
3H); 13C NMR (150 MHz, CDCl3): δ 190.4, 144.7, 138.2, 134.8, 132.7, 130.5, 128.9, 
128.6, 128.4, 128.4, 122.1. 
 
3-methyl-1-phenylbut-2-en-1-one (2-1-4n): (Known compound, See: P. N. Chatterjee, 
S. Roy, J. Org. Chem. 2010, 75, 4413-4423) 1H NMR (600 MHz, CDCl3): δ 7.92-7.94 (m, 
2H), 7.50-7.53 (m, 1H), 7.42-7.45 (m, 2H), 6.74-6.75 (m, 1H), 2.21 (d, J = 1.2 Hz, 3H), 
2.01 (d, J = 1.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 191.8, 156.6, 139.2, 132.2, 
128.4, 128.1, 121.1, 27.9, 21.1. 
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(E)-1-o-tolylhept-1-en-3-one (E-2-1-4o): (Known compound, See: N. Marion, P. 
Carlqvist, R. Gealageas, P. Fremont, F. Maseras, S. P. Nolan, Chem. Eur. J. 2007, 13, 
6437-6451) 1H NMR (600 MHz, CDCl3): δ 7.85 (d, J = 16.2 Hz, 1H), 7.56 (d, J = 7.8 Hz, 
1H), 7.25 (t, J = 7.2 Hz, 1H), 7.20 (t, J = 7.5 Hz, 2H), 6.66 (d, J = 16.2 Hz, 1H), 2.65 (t, J 
= 7.2 Hz, 2H), 2.43 (s, 3H), 1.67 (quintet, J = 7.5 Hz, 2H), 1.39 (sextet, J = 7.4 Hz, 2H), 
0.95 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 200.4, 139.6, 137.8, 133.5, 
130.7, 129.9, 127.1, 126.3, 126.2, 40.9, 26.4, 22.4, 19.6, 13.8. 
 
(E)-1-phenyl-3-p-tolylprop-2-en-1-one (E-2-1-4p): (Known compound, See: Y. Zhang, 
Y.-L. Shao, H.-S. Xu, W. Wang, J. Org. Chem. 2011, 76, 1472-1474) 1H NMR (600 MHz, 
CDCl3): δ 8.00-8.01 (m, 2H), 7.79 (d, J = 15.6 Hz, 1H), 7.53-7.57 (m, 3H), 7.47-7.50 (m, 
3H), 7.22 (d, J = 7.8 Hz, 2H), 2.38 (s, 3H); 13C NMR (150 MHz, CDCl3): δ 190.6, 144.9, 
141.0, 138.4, 132.6, 132.2, 129.7, 128.5, 128.4, 121.1, 21.5. 
 
(E)-1-cyclopropylhept-1-en-3-one (E-2-1-4q): (Known compound, See: M. N. Pennell, 
M. G. Unthank, P. Turner, T. D. Sheppard, J. Org. Chem. 2011, 76, 1479-1482) 1H 
NMR (600 MHz, CDCl3): δ 6.31 (dd, J = 15.6 Hz, 9.6 Hz, 1H), 6.21 (d, J = 15.6 Hz, 1H), 
2.48 (t, J = 7.5 Hz, 2H), 1.53-1.61 (m, 3H), 1.34 (sextet, J = 7.4 Hz, 2H), 0.95-0.99 (m, 
2H), 0.91 (t, J = 7.5 Hz, 3H), 0.64-0.66 (m, 2H); 13C NMR (150 MHz, CDCl3): δ 199.8, 
152.0, 127.2, 40.0, 26.5, 22.4, 14.5, 13.8, 8.8. 
 
1-cyclohexylidenehexan-2-one (2-1-4r): (Known compound, See: M. Yu, G. Li, S. 
Wang, L. Zhang, Adv. Synth. Catal. 2007, 349, 871-875) 1H NMR (600 MHz, CDCl3): δ 
5.97  (s,1H), 2.79 (t, J = 5.4 Hz, 2H), 2.40 (t, J = 7.2 Hz, 2H), 2.16 (t, J = 6.3 Hz, 2H), 
1.54-1.69 (m, 8H), 1.32 (sextet, J = 7.4 Hz, 2H), 0.91 (t, J = 7.5 Hz, 3H); 13C NMR (150 
MHz, CDCl3): δ 202.1, 161.4, 121.0, 44.2, 38.1, 29.9, 28.8, 27.9, 26.4, 26.3, 22.4, 13.9. 
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(E)-1-(2-methoxyphenyl)hept-1-en-3-one (E-2-1-4s): 1H NMR (600 MHz, CDCl3): δ 
7.91 (d, J = 16.8 Hz, 1H), 7.53 (d, J = 7.8 Hz, 1H), 7.35 (t, J = 8.1 Hz, 1H), 6.96 (t, J = 
7.5 Hz, 1H), 6.91 (d, J = 8.4 Hz, 1H), 6.78 (d, J = 16.2 Hz, 1H), 3.89 (s, 3H), 2.67 (t, J = 
7.5 Hz, 2H), 1.66 (quintet, J = 7.5 Hz, 2H), 1.38 (sextet, J = 7.4 Hz, 2H), 0.94 (t, J = 7.5 
Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 201.2, 158.3, 137.5, 131.5, 128.3, 126.9, 123.5, 
120.7, 111.1, 55.4, 40.1, 26.6, 22.4, 13.9. 
 
(E)-1-(2-chloro-5-nitrophenyl)hept-1-en-3-one (E-2-1-4t): 1H NMR (600 MHz, CDCl3): 
δ 8.04 (d, J = 1.8 Hz, 1H), 7.67 (dd, J = 7.8 Hz, 1.8 Hz, 1H), 7.58 (d, J = 8.4 Hz, 1H), 
7.50 (d, J = 16.2 Hz, 1H), 6.80 (d, J = 15.6 Hz, 1H), 2.67 (t, J = 7.5 Hz, 2H), 1.67 
(quintet, J = 7.5 Hz, 2H), 1.38 (sextet, J = 7.4 Hz, 2H), 0.95 (t, J = 7.2 Hz, 3H); 13C NMR 
(150 MHz, CDCl3): δ 199.5, 148.3, 137.8, 134.8, 132.4, 132.0, 128.8, 128.2, 124.5, 41.3, 
26.1, 22.3, 13.8; HRMS Calculated for [C13H14ClNO3+Na]+: 290.05599, Found: 
290.05585. 
 
(E)-1-(naphthalen-4-yl)hept-1-en-3-one (E-2-1-4u): (Known compound, See: R. S. 
Ramón, N. Marion, S. P. Nolan, Tetrahedron, 2009, 65, 1767-1773) 1H NMR (600 MHz, 
CDCl3): δ 8.40 (d, J = 16.2 Hz, 1H), 8.17 (d, J = 8.4 Hz, 1H), 7.88 (t, J = 9.0 Hz, 2H), 
7.76 (d, J = 7.2 Hz, 1H), 7.57 (t, J = 7.5 Hz, 1H), 7.52 (t, J = 7.5 Hz, 1H), 7.48 (t, J = 7.8 
Hz, 1H), 6.83 (d, J = 16.2 Hz, 1H), 2.73 (t, J = 7.5 Hz, 2H), 1.72 (quintet, J = 7.5 Hz, 2H), 
1.42 (sextet, J = 7.4 Hz, 2H), 0.97 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 
200.4, 139.1, 133.7, 132.0, 131.6, 130.6, 128.8, 128.7, 126.8, 126.2, 125.4, 125.0, 
123.3, 41.1, 26.5, 22.5, 13.9. 
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2.2 Ambient intermolecular [2+2] cycloaddition of allene intermediate 
I. General methods and materials 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out 
under an atmosphere of nitrogen using oven/flame-dried glassware. Unless otherwise 
noted, all commercial reagents were obtained from the commercial provider and used 
without further purification. Anhydrous solvents were used after general distillation 
strategies (Na for THF and CaH2 for DCM). All gold complexes were synthesized from 
HAuCl4, which was purchased from Strem. XPhos was purchased from Acros and used 
as received (stored at 4 oC and handled in glovebox). 1H NMR, and 13C NMR spectra 
were recorded on Varian 600 MHz and Agilent 400 MHz spectrometers. Chemical shifts 
were reported relative to internal tetramethylsilane (δ 0.00 ppm) or CDCl3 (δ 7.26 ppm) 
for 1H and CDCl3 (δ 77.0 ppm) for 
13C. Flash column chromatography was performed on 
230-430 mesh silica gel. HRMS were recorded on LTQ-FTUHRA spectrometer. 
General procedure of propargyl ester 
 
Reaction conditions: To a solution of alkyne (12 mmol) in anhydrous THF (50 mL) at –
78 °C under N2 was added n-BuLi (2.5 M solution in hexanes, 5.0 mL, 12.5 mmol). The 
reaction was stirred at this temperature for 20 min then aldehyde (10 mmol) was added 
to the mixture and was allowed to warm to room temperature gradually and stirred for 
an additional hour (TLC monitored untill the aldehyde was consumed completely). 10 
Mins after addition of 0.5 eq. of H2O, PivCl (25 mmol) and TEA (20 eq.) were added at 
room temperature and stirred for 6 h. The mixture was extracted with EtOAc (3 x 20 mL), 
and the combined organic phases were washed with water and brine, dried with 
anhydrous MgSO4, and filtered. The filtrate was concentrated, and the residue was 
purified through silica gel flash column chromatography (hexanes/ethyl acetate = 20/1) 
to yield the desired pivalate ester (70 % - 90 %). 
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II. Compounds characterization 
 
3-phenyl-1-(p-tolyl)prop-2-yn-1-yl pivalate (2-2-1c). Pale yellow solid; 1H-NMR (CDCl3, 400MHz, 
ppm) δ = 7.47-7.44 (m, 4H), 7.32-7.27 (m, 3H), 7.19 (d, J = 8.0 Hz, 2H), 6.64 (s, 1H), 2.36 (s, 3H), 
1.23 (s, 9H); 13C-NMR (CDCl3, 100MHz, ppm) δ = 177.22, 138.51, 134.59, 131.86, 129.25, 128.60, 
128.21, 127.39, 122.35, 86.53, 86.0, 65.71, 38.76, 26.99, 21.19; HRMS calcd for C21H22O2Na 
[M+Na]+: 329.1512, found 329.1512.  
 
1,3-diphenylprop-2-yn-1-yl pivalate (2-2-1d). Pale yellow solid; 1H-NMR (CDCl3, 400MHz, ppm) δ 
= 7.58-7.56 (m, 2H), 7.48-7.45 (m, 2H), 7.42-7.34 (m, 3H), 7.33-7.24 (m, 3H), 6.68 (s, 1H), 1.24 (s, 
9H); 13C-NMR (CDCl3, 100MHz, ppm) δ = 177.20, 137.49, 131.88, 128.68, 128.65, 128.58, 128.24, 
127.38, 122.27, 86.72, 85.81, 65.80, 38.79, 26.99; HRMS calcd for C20H20O2Na [M+Na]+: 315.1356, 
found 315.1356. 
 
1-(4-(tert-butyl)phenyl)-3-phenylprop-2-yn-1-yl pivalate (2-2-1e). Pale yellow solid; 1H-NMR 
(CDCl3, 400MHz, ppm) δ = 7.51-7.45 (m, 4H), 7.42-7.39 (m, 2H), 7.33-7.28 (m, 3H), 6.65 (s, 1H), 
1.33 (s, 9H), 1.24 (s, 9H); 13C-NMR (CDCl3, 100 MHz, ppm) δ = 177.29, 151.65, 134.44, 131.89, 
128.61, 128.22, 127.11, 125.53, 122.40, 86.50, 86.06, 65.63, 38.82, 31.30, 27.03; HRMS calcd for 
C24H28O2Na [M+Na]+: 371.1982, found 371.1982. 
 
1-(4-bromophenyl)-3-phenylprop-2-yn-1-yl pivalate (2-2-1f). Pale yellow solid; 1H-NMR (CDCl3, 
400MHz, ppm) δ = 7.54-7.51 (m, 2H), 7.47-7.43 (m, 4H), 7.34-7.31 (m, 3H), 6.62 (s, 1H), 1.23 (s, 
9H); 
13
C-NMR (CDCl3, 100 MHz, ppm) δ = 177.11, 136.62, 131.89, 131.78, 129.14, 128.86, 128.30, 
122.82, 122.01, 87.09, 85.22, 65.19, 38.79, 26.97; HRMS calcd for C20H19BrO2Na [M+Na]+: 
393.0461, found 393.0461. 
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1-(4-chlorophenyl)-3-phenylprop-2-yn-1-yl pivalate (2-2-1g). Pale yellow solid; 1H-NMR (CDCl3, 
400MHz, ppm) δ = 7.53-7.49 (m, 2H), 7.47-7.44 (m, 2H), 7.38-7.35 (m, 2H),7.33-7.30 (m, 3H), 6.63 
(s, 1H), 1.23 (s, 9H); 
13
C-NMR (CDCl3, 100 MHz, ppm) δ = 177.13, 147.0, 136.10, 134.63, 131.90, 
128.85, 128.83, 128.30, 122.04, 87.07, 85.30, 65.15, 38.80, 26.97; HRMS calcd for C20H19ClO2Na 
[M+Na]+: 349.0966, found 349.0967. 
 
1-(4-fluorophenyl)-3-phenylprop-2-yn-1-yl pivalate (2-2-1h). Pale yellow solid; 1H-NMR (CDCl3, 
400MHz, ppm) δ = 7.58-7.53 (m, 2H), 7.48-7.45 (m, 2H), 7.34-7.30 (m, 3H), 7.10-7.05 (m, 2H), 6.65 
(s, 1H), 1.23 (s, 9H); 
13
C-NMR (CDCl3, 100 MHz, ppm) δ = 177.15, 162.85 (d, J = 236.7 Hz), 133.44 
(d, J = 3.8 Hz), 131.87, 129.37 (d, J = 8.4 Hz), 128.80, 128.28, 122.10, 115.53 (d, J = 21.3 Hz), 
86.94, 85.54, 65.17, 38.77, 26.96; HRMS calcd for C20H19FO2Na [M+Na]+: 333.1261, found 
333.1262. 
 
1-(4-methoxyphenyl)-3-phenylprop-2-yn-1-yl pivalate (2-2-1i). Pale yellow solid; 1H-NMR (CDCl3, 
400MHz, ppm) δ = 7.52-7.49 (m, 2H), 7.48-7.45 (m, 2H), 7.33-7.30 (m, 3H), 6.93-6.90 (m, 2H), 6.63 
(s, 1H), 3.82 (s, 3H), 1.22 (s, 9H); 
13
C-NMR (CDCl3, 100 MHz, ppm) δ = 177.29, 159.87, 131.86, 
129.72, 128.97, 128.62, 128.23, 122.35, 113.91, 86.52, 86.05, 65.57, 55.28, 38.77, 26.99; HRMS 
calcd for C21H22O3Na [M+Na]+: 345.1461, found 345.1461. 
 
1-(3-fluorophenyl)-3-phenylprop-2-yn-1-yl pivalate (2-2-1j). Pale yellow solid; 1H-NMR (CDCl3, 
400MHz, ppm) δ = 7.48-7.45 (m, 2H), 7.39-7.28 (m, 6H), 7.07-7.03 (m, 1H), 6.66 (s, 1H), 1.25 (s, 
9H); 
13
C-NMR (CDCl3, 100 MHz, ppm) δ = 177.07, 162.80 (d, J = 245.9 Hz), 139.92 (d, J = 6.8 Hz), 
131.90, 130.15 (d, J = 8.3 Hz), 128.86, 128.29, 122.98 (d, J = 3.0 Hz), 122.00, 115.63 (d, J = 21.2 
Hz), 114.37 (d, J = 22.8 Hz), 87.05, 85.15, 65.06 (d, J = 2.2 Hz), 38.81, 26.98; HRMS calcd for 
C20H19FO2Na [M+Na]+: 333.1261, found 333.1262. 
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methyl 4-(3-phenyl-1-(pivaloyloxy)prop-2-yn-1-yl)benzoate (2-2-1k). Pale yellow solid; 1H-NMR 
(CDCl3, 400MHz, ppm) δ = 8.09-8.06 (m, 2H), 7.66-7.62 (m, 2H), 7.48-7.45 (m, 2H), 7.35-7.29 (m, 
3H), 6.71 (s, 1H), 3.92 (s, 3H), 1.25 (s, 9H); 
13
C-NMR (CDCl3, 100 MHz, ppm) δ = 177.05, 166.61, 
142.28, 131.89, 130.39, 129.94, 128.88, 128.28, 127.25, 121.96, 87.29, 85.08, 65.26, 52.17, 38.81, 
26.96; HRMS calcd for C20H20O2Na [M+Na]+: 373.1410, found 373.1411. 
 
1-(2-methylphenyl)-3-phenylprop-2-yn-1-yl pivalate (2-2-1l). Pale yellow solid; 1H-NMR (CDCl3, 
400MHz, ppm) δ = 7.66-7.63 (m, 1H), 7.45-7.42 (m, 2H), 7.31-7.28 (m, 3H), 7.27-7.24 (m, 2H), 7.22-
7.19 (m, 1H), 6.75 (s, 1H), 2.48 (s, 3H) 1.24 (s, 9H); 
13
C-NMR (CDCl3, 100 MHz, ppm) δ = 177.08, 
136.27, 135.46, 131.83, 130.77, 128.68, 128.59, 128.21, 127.83, 126.14, 122.37, 86.52, 85.64, 
64.20, 38.87, 27.04, 19.07; HRMS calcd for C21H22O2Na [M+Na]+: 329.1512, found 329.1513. 
 
1-(2-bromophenyl)-3-phenylprop-2-yn-1-yl pivalate (2-2-1m). Pale yellow solid; 1H-NMR (CDCl3, 
400MHz, ppm) δ = 7.84-7.81 (m, 1H), 7.60-7.57 (m, 1H), 7.48-7.45 (m, 2H), 7.40-7.35 (m, 1H), 7.33-
7.28 (m, 3H), 7.25-7.19 (m, 1H), 6.88 (s, 1H), 1.25 (s, 9H); 
13
C-NMR (CDCl3, 100 MHz, ppm) δ = 
176.73, 136.56, 133.09, 131.90, 130.23, 129.47, 128.75, 128.22, 127.65, 123.28, 122.13, 87.09, 
84.83, 65.55, 38.84, 27.05; HRMS calcd for C20H19BrO2Na [M+Na]+: 393.0461, found 393.0462. 
 
1-(2-fluorophenyl)-3-phenylprop-2-yn-1-yl pivalate (2-2-1n). Pale yellow solid; 1H-NMR (CDCl3, 
400MHz, ppm) δ = 7.60-7.71 (m, 1H), 7.49-7.46 (m, 2H), 7.37-7.28 (m, 4H), 7.22-7.18 (m, 1H), 7.11-
6.90 (m, 1H), 6.90 (s, 1H), 1.24 (s, 9H); 
13
C-NMR (CDCl3, 100 MHz, ppm) δ = 176.85, 160.21 (d, J = 
249 Hz), 131.92, 130.60 (d, J = 8.4 Hz), 129.27 (d, J = 3.8 Hz), 128.77, 128.24, 124.78, 124.22 (d, J 
= 3.8 Hz), 122.12, 115.66 (d, J = 20.5 Hz), 86.86, 84.67, 60.32 (d, J = 5.3 Hz), 38.78, 26.97; HRMS 
calcd for C20H19FO2Na [M+Na]+: 333.1261, found 333.1262. 
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1-(naphthalen-2-yl)-3-phenylprop-2-yn-1-yl pivalate (2-2-1o). Pale yellow solid; 1H-NMR (CDCl3, 
400MHz, ppm) δ = 8.04 (s, 1H), 8.04-7.81 (m, 3H), 7.68-7.65 (m, 1H), 7.51-7.45 (m, 4H), 7.32-7.27 
(m, 3H), 6.85 (s, 1H), 1.25 (s, 9H); 
13
C-NMR (CDCl3, 100 MHz, ppm) δ = 177.17, 134.80, 133.33, 
133.03, 131.87, 128.70, 128.55, 128.25, 128.24, 127.65, 126.76, 126.50, 126.32, 124.93, 122.23, 
87.03, 85.81, 66.01, 38.81, 26.99; HRMS calcd for C24H22O2Na [M+Na]+: 365.1512, found 365.1512. 
 
3-(4-methoxyphenyl)-1-(p-tolyl)prop-2-yn-1-yl pivalate (2-2-1p). Pale yellow solid; 1H-NMR 
(CDCl3, 400MHz, ppm) δ = 7.46-7.44 (m, 2H), 7.42-7.37 (m, 2H), 7.20-7.18 (m, 2H), 6.85-6.80 (m, 
2H), 6.62 (s, 1H), 3.80 (s, 3H), 2.36 (s, 3H), 1.22 (s, 9H); 
13
C-NMR (CDCl3, 100 MHz, ppm) δ = 
177.28, 159.86, 138.43, 134.83, 133.38, 129.22, 127.38, 114.45, 113.84, 86.53, 84.66, 65.86, 55.26, 
38.77, 27.00, 21.20; HRMS calcd for C22H24O3Na [M+Na]+: 359.1618, found 359.1618. 
 
methyl 4-(3-(pivaloyloxy)-3-(p-tolyl)prop-1-yn-1-yl)benzoate (2-2-1q). Pale yellow solid; 1H-NMR 
(CDCl3, 400MHz, ppm) δ = 7.98 (d, J = 8.0 Hz, 2H), 7.51 (d, J = 8.0 Hz, 2H), 7.45 (d, J = 8.0 Hz, 2 
H), 7.21 (d, J = 8.0 Hz, 2H), 6.63 (s, 1H), 3.91 (s, 3H), 2.37 (s, 3H), 1.23 (s, 9H); 
13
C-NMR (CDCl3, 
100 MHz, ppm) δ = 177.17, 166.41, 138.72, 134.20, 131.77, 129.91, 129.38, 129.34, 127.36, 126.99, 
88.98, 85.65, 65.58, 52.21, 38.78, 26.98, 21.20; HRMS calcd for C23H24O4Na [M+Na]+: 387.1567, 
found 387.1567. 
 
1-(p-tolyl)-3-(4-(trifluoromethyl)phenyl)prop-2-yn-1-yl pivalate (2-2-1r). Pale yellow solid; 1H-
NMR (CDCl3, 400MHz, ppm) δ = 7.56 (s, 4H), 7.45 (d, J = 8.0 Hz, 2H), 7.21 (d, J = 8.0 Hz, 2H), 6.63 
(s, 1H), 2.37 (s, 3H), 1.24 (s, 9H); contaminant: 
1
H-NMR (CDCl3, 400MHz, ppm) δ = 7.68 (d, J = 8.4 
Hz, 2H), 7.64 (d, J = 8.4 Hz, 2H), 1.29 (s, 9H); HRMS calcd for C22H21F3O2Na [M+Na]+: 397.1386, 
found 397.1388. 
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III General procedure of [2+2] cycloaddition 
Reaction conditions: To a solution of 2-2-1c (61.2 mg, 0.20 mmol) in dry CH2Cl2 (0.8 mL, 0.25 
M), was added [PPh3Au(TA-Me)]OTf (1.5 mg, 0.002 mol, 1.0 mol%) at RT. The reaction mixture was 
stirred at room temperature. After the reaction was completed (20 h), 0.1 mmol of 1,3,5-
trimethoxybenzene (16.8mg) was added into the reaction mixture, and the solvent was removed 
under reduced pressure and the crude 1H NMR give the crude yield: 66 % of 2-2-3c, and 13 % of 2-
2-3c’. Purification of 2-2-3c and 2-2-3c’: After silica column (Ethyl Acetate / Hexane = 1 / 10), crude 
product containing 2-2-3c and 2-2-3c’ in the test tube was further purification by slow evaporation. 
Pure 2-2-3c was obtained in the bottom of test tube and was washed with hexane. The pure 2-2-3c’ 
was obtained by prepared TLC of the residue in the test tube. 
 
IV. Compounds characterization 
 
(Z)-2-(4-methylbenzylidene)-1,5-diphenyl-3-(p-tolyl)pent-4-yn-1-one (2-2-2b). Yellow liquid; 1H-
NMR (CDCl3, 400MHz, ppm) δ = 7.73 (d, J = 8.0 Hz, 2H), 7.37 (d, J = 8.0 Hz, 2H), 7.33-7.24 (m, 6H), 
7.23-7.15 (m, 2H), 7.11-7.07 (m, 3H), 6.99 (d, J= 8.0 Hz, 2H), 6.84(d, J = 8.0 Hz, 2H), 5.19 (s, 1H), 
2.28 (s, 3H), 2.12 (s, 3H); 
13
C-NMR (CDCl3, 100 MHz, ppm) δ = 199.55, 139.50, 137.66, 136.93, 
136.50, 135.45, 132.80, 132.45, 131.55, 131.39, 129.47, 129.28, 128.83, 128.73, 128.30, 128.12, 
128.05, 127. 98, 123.20, 88.46, 86.53, 43.24, 21.06, 21.04;  
 
(2Z,3Z)-2-(4-methylbenzylidene)-1-phenyl-3-(phenyl(pivaloyloxy)methylene)-4-(p-tolyl) 
cyclobutyl pivalate (2-2-3b). Colorless Solid; 1H-NMR (CDCl3, 600MHz, ppm) δ = 7.20-7.18 (m, 
2H), 7.17 (d, J = 9.6 Hz, 2H), 7.14-7.12 (m, 2H), 7.10 (s, 1H), 7.03-6.99 (m, 6H), 6.96 (d, J = 9.6 Hz, 
2H), 6.68 (d, J = 7.2 Hz, 2H), 6.57 (d, J = 7.2 Hz, 2H), 5.71 (s, 1H), 2.48 (s, 3H), 2.25 (s, 3H), 2.03 (s, 
3H), 2.02 (s, 3H); 
13
C-NMR (CDCl3, 125 MHz, ppm) δ = 169.57, 169.06, 141.52, 138.07, 137.85, 
136.20, 135.53, 133.40, 132.17, 131.83, 129.32, 129.21, 129.03, 127.85, 127.70, 127.58, 127.50, 
127.41, 127.07, 126.76, 126.39, 90.65, 57.37, 21.68, 21.22, 20.91;  
2-2-3b and 2-2-3b’: 2-2-1b (61.2 mg, 0.20 mmol) was used, and the NMR show that: 66 % yield of 
2-2-3b [
1
H-NMR (CDCl3, 400MHz, ppm) δ = 6.66 (d, J = 8.0 Hz, 2H), 6.53 (d, J = 8.0 Hz, 2H), 5.67 
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(s, 1H), 2.22 (s, 3H), 2.15 (s, 3H), 1.52 (s, 9H), 1.17 (s, 9H)], and 13 % yield of 2-2-3b’ [1H-NMR 
(CDCl3, 400MHz, ppm) δ = 4.34 (s, 1H), 2.15 (s, 3H), 1.42 (s, 9H)]. 
 
(2Z,3Z)-2-(4-methylbenzylidene)-1-phenyl-3-(phenyl(pivaloyloxy)methylene)-4-(p-tolyl)cyc 
lobutyl pivalate (2-2-3c). Colorless Solid; 1H-NMR (CDCl3, 400MHz, ppm) δ = 7.24-7.21 (m, 2H), 
7.15-7.10 (m, 5H), 7.04-6.97 (m, 6H), 6.93 (d, J= 8.4 Hz, 2H), 6.65 (d, J = 7.6 Hz, 2H), 6.53 (d, J = 
7.6 Hz, 2H), 5.66 (s, 1H), 2.23 (s, 3H), 2.01 (s, 3H), 1.52 (s, 9H), 1.17 (s, 9H); 
13
C-NMR (CDCl3, 100 
MHz, ppm) δ = 176.99, 176.27, 141.57, 138.23, 137.65, 136.68, 135.34, 133.99, 132.23, 131.94, 
129.37, 129.19, 128.97, 127.74, 127.73, 127.61, 127.58, 127.49, 127.33, 126.71, 126.68, 126.46, 
90.12, 57.26, 39.53, 27.66, 27.27, 21.20, 21.19, 20.92; HRMS calcd for C42H44O4Na [M+Na]+: 
635.3132, found 635.3134. 
 
(1Z,1'Z)-(3,4-di-p-tolylcyclobutane-1,2-diylidene)bis(phenylmethanylylidene)bis 
(2,2-dimethylpropanoate) (2-2-3c’). Colorless solid; 1H-NMR (CDCl3, 400MHz, ppm) δ = 7.16 (d, J 
= 5.2 Hz, 4H), 7.01 (s, 10H), 6.85 (d, J = 5.2Hz, 4H), 4.33 (s, 2H), 2.16 (s, 6H), 1.42 (s, 18H); 
13
C-
NMR (CDCl3, 100 MHz, ppm) δ = 177.56, 140.17, 135.88, 135.63, 133.05, 132.15, 128.65, 128.26, 
127.87, 127.54, 126.70, 59.47, 39.42, 27.39, 21.03; HRMS calcd for C42H44O4Na [M+Na]+: 635.3132, 
found 635.3134.  
 
 
2-2-3d and 2-2-3d’: 2-2-1d (58.5 mg, 0.20 mmol) was used, and the NMR show that: 79 % yield of 
2-2-3d [
1
H-NMR (CDCl3, 400MHz, ppm) δ = 6.79-6.74 (m, 5H), 5.73 (s, 1H), 1.53 (s, 9H), 1.15 (s, 
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9H)], and 13 % yield of 2-2-3d’ [1H-NMR (CDCl3, 400MHz, ppm) δ = 4.42 (s, 1H), 1.43 (s, 9H)]. 
HRMS calcd for C40H40O4H [M+H]+: 585.2999, found 585.3002.  
 
2-2-3e and 2-2-3e’: 2-2-1e (34.8 mg, 0.10 mmol) was used, and the NMR show that: 65 % yield of 2-
2-3e [
1
H-NMR (CDCl3, 400MHz, ppm) δ = 6.71 (d, J = 8.0 Hz, 2H), 6.62 (d, J = 8.0 Hz, 2H), 5.67 (s, 
1H), 1.51 (s, 9H), 1.21 (s, 9H), 1.10 (s, 9H), 1.04 (s, 9H)], and 19 % yield of 2-2-3e’ [1H-NMR (CDCl3, 
400MHz, ppm) δ = 4.40 (s, 1H), 1.42 (s, 9H), 1.16 (s, 9H)]. 
 
2-(4-(tert-butyl)benzylidene)-4-(4-(tert-butyl)phenyl)-1-phenyl-3-(phenyl(pivaloyloxy)methy 
lene)cyclobutyl pivalate (2-2-3e). Colorless solid; 1H-NMR (CDCl3, 400MHz, ppm) δ = 7.23-7.14 
(m, 8H), 7.12-7.09 (m, 2H), 7.04-6.95 (m, 8H), 6.71 (d, J = 8.4 Hz, 2H), 6.61 (d, J = 8.4 Hz, 2H), 5.66 
(s, 1H), 1.51 (s, 9H), 1.21 (s, 9H), 1.10 (s, 9H), 1.04 (s, 9H); 
13
C-NMR (CDCl3, 150 MHz, ppm) δ = 
177.0, 176.3, 150.7, 141.6, 137.0, 133.9, 132.3, 131.9, 129.1, 128.9, 127.7, 127.6, 127.5, 127.4, 
127.2, 126.7, 126.4, 125.2, 123.8, 110.0, 90.2, 57.2, 39.5, 34.5, 34.0, 31.3, 31.1, 31.1, 29.7, 27.6, 
27.4, 27.2; HRMS calcd for C48H56O4H [M+H]+: 697.4251, found 697.4252. 
 
(1Z,1'Z)-(3,4-bis(4-(tert-butyl)phenyl)cyclobutane-1,2-diylidene)bis(phenylmethanylylidene) 
bis(2,2-dimethylpropanoate) (2-2-3e’). Colorless solid; 1H-NMR (CDCl3, 400MHz, ppm) δ = 7.21 (d, 
J = 8.4 Hz, 2H), 7.03 (d, J = 8.4 Hz, 2H), 6.96 (s, 5H), 4.40 (s, 1H), 1.42 (s, 9H), 1.16 (s, 9h); 
13
C-
NMR (CDCl3, 150 MHz, ppm) δ = 177.6, 149.2, 135.3, 133.0, 132.9, 128.3, 127.7, 127.4, 126.7, 
125.2, 124.7, 58.7, 39.4, 34.2, 31.9, 31.3, 31.1, 29.7, 27.6, 27.4; HRMS calcd for C48H56O4H [M+H]+: 
697.4251, found 697.4254.  
 
2-2-3f and 2-2-3f’: 2-2-1f (74.0 mg, 0.20 mmol) was used, and the NMR show that: 74 % yield of 2-
2-3f [1H-NMR (CDCl3, 400MHz, ppm) δ = 6.86 (d, J = 8.0 Hz, 2H), 6.66 (d, J = 8.0 Hz, 2H), 5.66 (s, 
1H), 1.51 (s, 9H), 1.17 (s, 9H)], and 16 % yield of 2-2-3f’ [1H-NMR (CDCl3, 400MHz, ppm) δ = 4.32 
(s, 1H), 1.42 (s, 9H)]. 
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2-(4-bromobenzylidene)-4-(4-bromophenyl)-1-phenyl-3-(phenyl(pivaloyloxy)methylene)cycl 
obutyl pivalate (2-2-3f). Colorless solid; 1H-NMR (CDCl3, 400MHz, ppm) δ = 7.24 (s, 1H), 7.21-7.17 
(m, 2H), 7.11-7.01 (m, 11H), 6.86 (d, J = 8.0 Hz, 2H), 6.66 (d, J = 8.0Hz), 5.65 (s, 1H), 1.51 (s, 9H), 
1.17 (s, 9H); 
13
C-NMR (CDCl3, 150 MHz, ppm) δ =177.1, 176.2, 143.4, 142.6, 139.8, 135.9, 134.1, 
133.7, 133.6, 132.9, 132.2, 131.4, 131.0, 130.7, 130.2, 129.8, 128.7, 128.5, 128.4, 128.0, 127.9, 
127.8, 127.3, 126.5, 125.6, 125.5, 121.9, 120.2, 89.7, 56.9, 39.6, 39.5, 27.6, 27.2; HRMS calcd for 
C40H38Br2O4H [M+H]+: 741.1210, found 741.1211. 
 
(1Z,1'Z)-(3,4-bis(4-bromophenyl)cyclobutane-1,2-diylidene)bis(phenylmethanylylidene) 
bis(2,2-dimethylpropanoate) (2-2-3f’). Colorless solid; 1H-NMR (CDCl3, 400MHz, ppm): δ = 7.18-
7.11 (m, 4H), 7.07-6.96 (m, 5H), 4.31 (s, 1H), 1.42 (9H); 
13
C-NMR (CDCl3, 150 MHz, ppm) δ = 177.7, 
140.5, 137.1, 132.7, 131.2, 130.9, 130.1, 128.5, 127.8, 126.8, 120.6, 59.1, 39.5, 27.4; HRMS calcd 
for C40H38Br2O4H [M+H]+: 741.1210, found 741.1213.  
 
2-2-3g and 2-2-3g’: 2-2-1g (32.6 mg, 0.10 mmol) was used, and the NMR show that: 80 % yield of 
2-2-3g [1H-NMR (CDCl3, 400MHz, ppm) δ = 6.72 (s, 4H), 5.67 (s, 1H), 1.51 (s, 9H), 1.17 (s, 9H)], 
and 17 % yield of 2-2-3g’ [1H-NMR (CDCl3, 400MHz, ppm) δ = 4.33 (s, 1H), 1.42 (s, 9H)].  
 
2-(4-chlorobenzylidene)-4-(4-chlorophenyl)-1-phenyl-3-(phenyl(pivaloyloxy)methylene)cycl 
obutyl pivalate (2-2-3g). Colorless solid; 1H-NMR (CDCl3, 400MHz, ppm) δ = 7.21-7.15 (m, 4H), 
7.12-7.06 (m, 8H), 7.03-7.01 (m, 3H), 6.71 (s, 4H), 5.66 (s, 1H), 1.51 (s, 9H), 1.17 (s, 9H); 
13
C-NMR 
(CDCl3, 150 MHz, ppm) δ = 177.1, 176.2, 143.3, 142.5, 139.7, 136.0, 133.6, 133.5, 133.3, 132.9, 
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131.9, 130.6, 130.4, 129.7, 129.6, 129.3, 128.7, 128.5, 128.4, 128.3, 128.2, 128.0, 127.9, 127.7, 
127.3, 127.2, 126.8, 126.5, 125.5, 122.5, 89.8, 56.9, 39.6, 39.5, 27.6, 27.3; HRMS calcd for 
C40H38Cl2O4H [M+H]+: 653.2220, found 653.2222. 
 
2-(4-chlorobenzylidene)-4-(4-chlorophenyl)-1-phenyl-3-(phenyl(pivaloyloxy)methylene)cycl 
obutyl pivalate (2-2-3g’). Colorless solid; 1H-NMR (CDCl3, 400MHz, ppm) δ = 7.20 (d, J = 8.4 Hz, 
2H), 7.05-6.95 (m, 7H), 4.33 (s, 1H), 1.42 (s, 9H); HRMS calcd for C40H38Cl2O4H [M+H]+: 653.2220, 
found 653.2223.  
 
2-2-3h and 2-2-3h’: 2-2-1h (62.0 mg, 0.20 mmol) was used, and the NMR show that: 76 % yield of 
2-2-3h [1H-NMR (CDCl3, 400MHz, ppm) δ = 6.43 (t, J = 8.8 Hz, 2H), 5.68 (s, 1H), 1.52 (s, 9H), 1.16 
(s, 9H)], and 19 % yield of 2-2-3h’ [1H-NMR (CDCl3, 400MHz, ppm) δ = 4.35 (s, 1H), 1.42 (s, 9H)]. 
 
2-(4-fluorobenzylidene)-4-(4-fluorophenyl)-1-phenyl-3-(phenyl(pivaloyloxy)methylene)cycl 
obutyl pivalate (2-2-3h). Colorless solid; 1H-NMR (CDCl3, 400MHz, ppm) δ = 7.24-7.19 (m, 4H), 
7.12-7.05 (m, 6H), 7.02-7.00 (m, 3H), 6.85-6.80 (m, 2H), 6.77-6.73 (m, 2H), 6.41 (t, J = 8.8 Hz, 2H), 
5.68 (s, 1H), 1.52 (s, 9H), 1.16 (s, 9H); 
13
C-NMR (CDCl3, 150 MHz, ppm) δ = 177.1, 176.3, 163.0, 
162.0, 161.4, 160.4, 142.1, 138.5, 136.3, 133.7, 131.1, 131.1, 131.0, 130.9, 130.8, 130.8, 128.2, 
128.0, 127.8, 127.6, 127.4, 126.5, 126.2, 125.6, 115.4, 115.3, 114.0, 113.9, 110.0, 90.0, 56.7, 39.5, 
30.0, 27.6, 27.2; HRMS calcd for C40H38F2O4H [M+Na]+: 621.2811, found 621.2814. 
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3,4-bis(4-fluorophenyl)cyclobutane-1,2-diylidene)bis(phenylmethanylylidene) 
bis(2,2-dimethylpropanoate (2-2-3h’). Colorless solid; 1H-NMR (CDCl3, 400MHz, ppm) δ = 7.24-
7.20 (m, 2H), 7.05-6.95 (m, 5H), 6.72-6.69  (m, 2H), 4.34 (s, 1H), 1.42 (s, 9H); 
13
C-NMR (CDCl3, 150 
MHz, ppm) δ = 177.8, 162.4, 160.8, 140.3, 133.8, 132.7, 131.7, 130.0, 129.9, 128.3, 127.6, 126.8, 
114.9, 114.7, 59.0, 39.5, 27.4; HRMS calcd for C40H38F2O4H [M+H]+: 643.2632, found 643.2630.  
 
2-2-3i and 2-2-3i’: 2-2-1i (64.4 mg, 0.20 mmol), [(PPh3Au)3O]OTf2
 
1 mol % was used instead of 
[PPh3Au(TA-Me)OTf] 1 mol %, and the NMR show that: 68 % yield of 2-2-3i [
1
H-NMR (CDCl3, 
400MHz, ppm) δ = 6.71 (d, J = 8.4 Hz, 2H), 6.67 (d, J = 9.6Hz, 2H), 6.29 (d, J = 8.4 Hz, 2H), 5.64 (s, 
1H), 3.72 (s, 3H), 3.54 (s, 3H), 1.52 (s, 9H), 1.17 (s, 9H)], and 12 % yield of 2-2-3i’ [1H-NMR (CDCl3, 
400MHz, ppm) δ = 6.58 (d, J = 8.8 Hz, 2H), 4.31 (s, 1H), 3.64 (s, 3H), 1.42 (s, 9H)]. 
 
(2Z,3Z)-2-(4-methoxybenzylidene)-4-(4-methoxyphenyl)-1-phenyl-3-(phenyl(pivaloyloxy)m 
ethylene)cyclobutyl pivalate (2-2-3i). 
Colorless Solid;
 1
H-NMR (CDCl3, 400MHz, ppm) δ = 7.24-7.18 (m, 4H), 7.12-7.09 (m, 3H), 7.07-6.97 
(m, 6H), 6.71 (d, J = 8.4 Hz, 2H), 6.67 (d, J = 9.6Hz, 2H), 6.29 (d, J = 8.4 Hz, 2H), 5.64 (s, 1H), 3.72 
(s, 3H), 3.54 (s, 3H), 1.52 (s, 9H), 1.17 (s, 9H); 
13
C-NMR (CDCl3, 100 MHz, ppm) δ = 177.09, 176.36, 
159.23, 157.73, 141.21, 136.72, 136.70, 133.94, 130.90, 130.42, 127.91, 127.73, 127.71, 127.62, 
127.51, 127.45, 127.42, 127.08, 126.44, 126.40, 113.76, 112.49, 90.34, 56.93, 55.22, 55.19, 54.92, 
54.90, 39.51, 27.67, 27.30; HRMS calcd for C42H44O6Na [M+Na]+: 667.3030, found 667.3031.  
 
2-2-3j and 2-2-3j’: 2-2-1j (62.0 mg, 0.20 mmol), and the NMR show that: 76 % yield of 2-2-3j [1H-
NMR (CDCl3, 400MHz, ppm) δ = 6.58 (d, J = 7.6 Hz, 1H), 6.50-6.43 (m, 2H), 5.69 (s, 1H), 1.52 (s, 
9H), 1.18 (s, 9H)], and 17 % yield of 2-2-3j’ [1H-NMR (CDCl3, 400MHz, ppm) δ = 4.39 (s, 1H), 1.43 
(s, 9H)].HRMS calcd for C40H38F2O4Na [M+Na]+: 643.2630, found 643.2633.  
2-2-3k and 2-2-3k’: 2-2-1k (70.0 mg, 0.20 mmol), and the NMR show that: 71 % yield of 2-2-3k [1H-
NMR (CDCl3, 400MHz, ppm) δ = 6.86 (d, J = 7.6 Hz, 2H), 5.78 (s, 1H), 3.84 (s, 3H), 3.75 (s, 3H), 
1.54 (s, 9H), 1.17 (s, 9H)], and 11 % yield of 2-2-3k’ [1H-NMR (CDCl3, 400MHz, ppm) δ = 4.48 (s, 
1H), 3.82 (s, 3H), 1.44 (s, 9H)]. HRMS calcd for C44H44O8H [M+H]+: 701.3109, found 701.3111.  
 
2-2-3l and 2-2-3l’: 2-2-1l (61.2 mg, 0.20 mmol), and the NMR show that: 73 % yield of 2-2-3k [1H-
NMR (CDCl3, 400MHz, ppm) δ = 6.64 (t, J = 7.6 Hz, 1H), 6.55 (d, J = 7.6 Hz, 1H), 6.31 (d, J = 7.6 Hz, 
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1H), 6.14 (s, 1H), 2.39 (s, 3H), 2.31 (s, 3H),1.49 (s, 9H), 0.92 (s, 9H)], and 18 % yield of 2-2-3k’ [1H-
NMR (CDCl3, 400MHz, ppm) δ = 4.72 (s, 1H), 1.90 (s, 3H), 1.45 (s, 9H)]. 
 
(2Z,3Z)-2-(2-methylbenzylidene)-1-phenyl-3-(phenyl(pivaloyloxy)methylene)-4-(o-tolyl)cycl 
obutyl pivalate (2-2-3l). Colorless solid; note: 12 % of 3k’ is contained in the 3k, so the 13C NMR 
can not be characterized. 
1
H-NMR (CDCl3, 400MHz, ppm) δ = 7.33-7.31 (m, 2H), 7.12-6.98 (m, 12H), 
6.82-6.74 (m, 2H), 6.64 (t, J = 7.6 Hz, 1H), 6.55 (d, J = 7.6 Hz, 1H), 6.31 (d, J = 7.6 Hz, 1H), 6.14 (s, 
1H), 2.39 (s, 3H), 2.31 (s, 3H), 1.49 (s, 9H), 0.92 (s, 9H); HRMS calcd for C42H44O4Na [M+Na]+: 
635.3132, found 635.3133. 
 
2-2-3m and 2-2-3m’: 2-2-1m (74.0 mg, 0.20 mmol), and the NMR show that: 63 % yield of 2-2-3m 
[
1
H-NMR (CDCl3, 400MHz, ppm) δ = 6.62-6.56 (m, 2H), 6.44 (s, 1H), 6.41-6.36 (m, 1H), 1.52 (s, 9H), 
1.00 (s, 9H)], and 18 % yield of 2-2-3m’ [1H-NMR (CDCl3, 400MHz, ppm) δ = 6.80 (dt, J1 = 2.0 Hz, J2 
= 8.0Hz, 1H), 5.13 (s, 1H), 1.45 (s, 9H)]. 
 
(2Z,3Z)-2-(2-bromobenzylidene)-4-(2-bromophenyl)-1-phenyl-3-(phenyl(pivaloyloxy)methy 
lene)cyclobutyl pivalate (2-2-3m). 1H-NMR (CDCl3, 400MHz, ppm) δ = 7.52 (d, J = 1.2 Hz, 1H), 
7.50 (s, 1H), 7.50-7.37 (m, 2H), 7.23-7.19 (m, 2H), 7.18-7.08 (m, 4H), 7.05-7.00 (m, 4H), 6.96-6.86 
(m, 2H), 6.62-6.56 (m, 2H), 6.44 (s, 1H), 6.41-6.36 (m, 1H), 1.52 (s, 9H), 1.00 (s, 9H); 
13
C-NMR 
(CDCl3, 100 MHz, ppm) δ = 176.71, 176.37, 142.20, 141.12, 137.96, 134.64, 134.38, 133.71, 132.82, 
131.64, 131.17, 130.03, 128.80, 128.27, 127.95, 127.66, 127.62, 127.57, 126.94, 126.80, 126.66, 
125.88, 125.43, 124.90, 124.68, 124.57, 89.50, 55.52, 39.40, 39.31, 27.59, 27.27; HRMS calcd for 
C40H38Br2O4Na [M+Na]+: 763.1029, found 763.1028.  
 
2-2-3n and 2-2-3n’: 2-2-1n (62.0 mg, 0.20 mmol), and the NMR show that: 74 % yield of 2-2-3n [1H-
NMR (CDCl3, 400MHz, ppm) δ = 6.52 (t, J = 8.0 Hz, 1H), 6.25 (t, J = 8.0 Hz, 1H), 6.14 (s, 1H), 1.53 
(s,9H), 1.20 (s, 9H)], and 18 % yield of 2-2-3n’ [1H-NMR (CDCl3, 400MHz, ppm) δ = 4.97 (s, 1H), 
1.43(s, 9H)]. 
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(2Z,3Z)-2-(2-fluorobenzylidene)-4-(2-fluorophenyl)-1-phenyl-3-(phenyl(pivaloyloxy)methyle 
ne)cyclobutyl pivalate (2-2-3n). 1H-NMR (CDCl3, 400MHz, ppm) δ = 7.25-7.23 (m, 2H), 7.15-7.00 
(m, 11H), 6.94 (d, J = 10.8 Hz, 1H), 6.83-6.78 (m, 1H), 6.71 (d, J = 8.0 Hz, 1H), 6.69-6.57 (m, 1H), 
6.51-6.43 (m, 2H), 5.68 (s, 1H),1.52 (s, 9H), 1.17 (s, 9H); 
13
C-NMR (CDCl3, 100 MHz, ppm) δ = 
177.08, 176.08, 163.79, 161.35, 160.72, 142.92, 140.49, 137.55, 137.47, 136.93, 135.92, 133.72, 
129.69, 129.61, 128.50, 128.42, 128.38, 127.94, 127.89, 127.74, 127.71, 127.26, 126.76, 126.56, 
125.56, 125.53, 125.32, 125.22, 125.20, 125.09, 125.06, 116.17, 115.95, 115.63, 115.41, 114.66, 
114.45, 113.15, 112.94, 89.63, 57.01, 56.99, 39.59, 27.59, 27.20; HRMS calcd for C40H38F2O4Na 
[M+Na]+: 643.2630, found 643.2631. 
 
2-2-3o and 2-2-3o’: 2-2-1o (68.4 mg, 0.20 mmol), and the NMR show that: 43 % yield of 2-2-3o [1H-
NMR (CDCl3, 400MHz, ppm) δ = 65.92 (s, 1H), 1.58 (s, 9H), 1.15 (s, 9H)], and 24 % yield of 2-2-3o’ 
[
1
H-NMR (CDCl3, 400MHz, ppm) δ = 5.13 (s, 1H), 1.11 (s, 9H)]. 
 
(3Z,4Z)-2-(naphthalen-2-yl)-4-(naphthalen-2-ylmethylene)-1-phenyl-3-(phenyl(pivaloyloxy) 
methylene)cyclobutyl pivalate (2-2-3o). 1H-NMR (CDCl3, 400MHz, ppm) δ = 7.70 (s, 1H), 7.68-
7.65 (m, 1H), 7.56-7.48 (m, 5H), 7.43-7.31 (m, 5H), 7.27-7.25 (m, 1H), 7.21-7.17 (m, 2H), 7.15-7.12 
(m, 1H), 6.98-6.85 (m, 7H), 5.92 (s, 1H), 1.58 (s, 9H), 1.15 (s, 9H); 
13
C-NMR (CDCl3, 100 MHz, ppm) 
δ = 177.13, 176.32, 142.43, 139.83, 136.54, 133.90, 133.21, 133.04, 132.70, 132.66, 132.61, 131.98, 
129.00, 128.65, 128.21, 128.03, 127.72, 127.64, 127.61, 127.57, 127.42, 127.26, 127.14, 126.88, 
126.86, 126.51, 126.48, 126.39, 126.20, 126.09, 125.05, 124.99, 90.09, 57.68, 39.61, 29.69, 27.72, 
27.27; HRMS calcd for C48H44O4Na [M+Na]+: 685.3312, found 685.3314. 
 
2-2-3p and 2-2-3p’: 2-2-1p (67.2 mg, 0.20 mmol), and the NMR show that: 66 % yield of 2-2-3p [1H-
NMR (CDCl3, 400MHz, ppm) δ = 5.58 (s, 1H), 3.65 (s, 3H), 3.63 (s, 3H), 2.23 (s, 3H), 2.04 (s, 3H), 
1.51 (s, 9H), 1.15 (s, 9H)], and 10 % yield of 2-2-3p’ [1H-NMR (CDCl3, 400MHz, ppm) δ = 4.29 (s, 
1H), 3.65 (s, 3H), 2.18 (s, 3H), 1.41 (s, 9H)]. 
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(4-methoxyphenyl)(3-(4-methoxyphenyl)-2-(4-methylbenzylidene)-3-(pivaloyloxy)-4-(p-toly 
l)cyclobutylidene)methyl pivalate (2-2-3p). 1H-NMR (CDCl3, 400MHz, ppm) δ = 7.16-7.12 (m, 4H), 
7.06 (s, 1H), 7.04 (d, J = 5.6 Hz, 2H), 6.93 (d, J = 5.6 Hz), 6.57 (d, J = 6.4Hz, 2H), 6.52 (d, J = 6.4Hz, 
2H), 5.57 (s, 1H), 3.66 (s, 3H), 3.65 (s, 3H), 2.24 (s, 3H), 2.05 (s, 3H), 1.51 (s, 9H), 1.15 (s, 9H)
;13
C-
NMR (CDCl3, 100 MHz, ppm) δ = 177.0, 176.4, 159.3, 159.1, 158.7, 141.5, 138.7, 137.4, 135.3, 
132.4, 132.3, 130.8, 129.7, 129.3, 129.2, 129.1, 129.0, 128.9, 128.8, 128.2, 128.0, 127.9, 127.8, 
127.1, 126.6, 125.8, 124.9, 113.8, 113.1, 113.0, 110.0, 90.0, 57.1, 55.1, 39.5, 39.4, 27.7, 
27.4;HRMS calcd for C44H48O6Na [M+H]+: 673.3524, found 673.3527. 
 
2-2-3q and 2-2-3q’: 2-2-1q (72.8 mg, 0.20 mmol), and the NMR show that no reaction occur. 
 
2-2-3r and 2-2-3r’: 2-2-1r (90 mg, 0.20 mmol), and the NMR show that no reaction occur. 
 
V Possible role of gold in allene [2+2] step 
Reaction conditions: To a solution of 2-2-1c (61.2 mg, 0.20 mmol) in dry, base-washed CDCl3 
(0.8 mL, 0.25 M), was added XphosAuNTf2 (2.0 mg, 0.002 mol, 1.0 mol%) at RT. The reaction 
mixture was monitored by 1H NMR. After 2-2-1c was transformed into allene 2-2-4 completely 
(around 5 mins), around half of reaction mixture went through the short silica gel column to remove 
the XphosAuNTf2 immediately, and another 3 portions of dry, based washed CDCl3 to washed the 
column, and the major part of solvent was removed in vacuo (make the concentration around 0.12M). 
1H NMR show that the 2+2 cycloaddition of allene 2-2-4 was consumed completely in 20 hours with 
or without XphosAuNTf2 (the same concentration, 0.12M). 
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1-phenyl-3-(p-tolyl)propa-1,2-dien-1-yl pivalate (2-2-4). 1H-NMR (CDCl3, 400MHz, ppm) δ = 7.43-
7.39 (m, 4H), 7.33 (t, J = 7.6 Hz, 2H), 7.28-7.24 (m, 1H), 7.16 (d, J = 8.0 Hz, 2H), 6.96 (s, 1H), 2.35 
(s, 3H), 1.37 (s, 9H). 
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VI. NMR spectra 
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Crude NMR Spectrum 
[1,3,5-trimethoxybenzene (0.1 mmol) was used as internal standard] 
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Chapter Three: Synthesis and characterization of bis-N-2-aryl triazole as efficient 
fluorescence probe  
I. General methods and materials and compounds characterization: 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried 
out under an atmosphere of nitrogen using oven dried glassware and standard 
syringe/septa techniques. Unless otherwise noted, all commercial reagents and 
solvents were obtained from the commercial provider and used without further 
purification. Chemical shifts were reported relative to internal tetramethylsilane (δ 0.00 
ppm) or CDCl3 (δ 7.26 ppm) for 
1H NMR and CDCl3 (δ 77.0 ppm) or d6-DMSO (δ 39.5 
ppm) for 13C NMR. 
  
Representative procedure for the preparation of 2-(anthracen-9-yl)-4-phenyl-
2H-1,2,3-triazole (3-1e) (Condition A) To a solution of 9-bromoanthracene (514 mg, 
2.0 mmol, 1.0 eq.) in dry DMSO (4 ml, 0.5 M), were added successively 4-Phenyl-1,2,3-
NH-triazole (725 mg, 5.0 mmol, 2.5 eq.) and CuI (76 mg, 20%), L-Proline (92 mg, 40%), 
and K2CO3 (1.1 g, 8.0 mmol, 4.0 eq.) under N2 atmosphere. The mixture was stirred at 
120oC and monitored by TLC. After the reaction is completed, the reaction was 
quenched with brine and extracted with ethyl acetate for three times. Organic phases 
were combined and the solvent was removed under vacuum. The residue was purified 
by flash silica gel chromatography (Hexane - EtOAc v/v 20:1), giving desired product as 
yellow solid (yield: 340 mg, 53%). 1H NMR (400 MHz; CDCl3): δ 8.66 (s, 1H), 8.37 (s, 
1H), 8.32 (dd, J = 5.8, 3.3 Hz, 1H), 8.09 (dd, J = 7.1, 1.9 Hz, 2H), 8.00-7.98 (m, 2H), 
7.79 (dd, J = 5.8, 3.3 Hz, 1H), 7.51-7.44 (m, 7H); 13C NMR (100 MHz; CDCl3): δ 148.94, 
134.1, 132.5, 131.3, 129.5, 129.00, 128.85, 128.70, 128.2, 127.6, 127.2, 126.2, 125.7, 
122.6; HRMS Calculated for C22H15N3 [M+H]
+: 322.1338, Found: 322.1342.  
 
Representative procedure for the preparation of 1-(anthracen-9-yl)-4-phenyl-
1H-1,2,3-triazole (3-1f) (Condition A) To a solution of 9-bromoanthracene (514 mg, 2.0 
mmol, 1.0 eq.) in dry DMSO (4 ml, 0.5 M), were added successively 4-Phenyl-1,2,3-NH-
triazole (725 mg, 5.0 mmol, 2.5 eq.) and CuI (76 mg, 20%), L-Proline (92 mg, 40%), and 
K2CO3 (1.1 g, 8.0 mmol, 4.0 eq.) under N2 atmosphere. The mixture was stirred at 120 
oC and monitored by TLC. After the reaction is completed, the reaction was quenched 
with brine and extracted with ethyl acetate for three times. Organic phases were 
combined and the solvent was removed under vacuum. The residue was purified by 
flash silica gel chromatography (Hexane - EtOAc v/v 15:1), giving desired product as 
light yellow solid (yield: 237 mg, 37%). 1H NMR (400 MHz; CDCl3): δ 8.69 (s, 1H), 8.20 
(s, 1H), 8.11 (d, J = 7.6 Hz, 2H), 8.03 (d, J = 8.4 Hz, 2H), 7.55-7.51 (m, 5H), 7.43-7.40 
(m, 2H); 13C NMR (100 MHz; CDCl3): δ 147.8, 131.2, 130.3, 129.8, 129.0, 128.46, 
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128.35, 128.0, 127.4, 126.7, 125.97, 125.89, 124.0, 122.1; HRMS Calculated for 
C22H15N3 [M+H]
+: 322.1338, Found: 322.1342. 
 
Representative procedure for the preparation of 1,8-bis(4-phenyl-2H-1,2,3-
triazol-2-yl)naphthalene (3-3c) (Condition A) To a solution of 1,8-diiodonaphthalene 
(760 mg, 2.0 mmol, 1.0 eq.) in dry DMSO (4 ml, 0.5 M), were added successively 4-
Phenyl-1,2,3-NH-triazole (725 mg, 5.0 mmol, 2.5 eq.) and CuI (76 mg, 20%), L-Proline 
(92 mg, 40%), and K2CO3 (1.1 g, 8.0 mmol, 4.0 eq.) under N2 atmosphere. The mixture 
was stirred at 120 oC and monitored by TLC. After the reaction is completed, the 
reaction was quenched with brine and extracted with ethyl acetate for three times. 
Organic phases were combined and the solvent was removed under vacuum. The 
residue was purified by flash silica gel chromatography (Hexane - EtOAc v/v 5:1), giving 
desired product as light yellow solid (yield: 472 mg, 57%). 1H NMR (400 MHz; CDCl3): δ 
8.12 (dd, J = 8.4, 1.2 Hz, 2H), 7.96 (dd, J = 7.4, 1.2 Hz, 2H), 7.71 (dd, J = 8.2, 7.4 Hz, 
2H), 7.48-7.51 (m, 4H), 7.28-7.22 (m, 6H); 13C NMR (100 MHz; CDCl3): δ 148.3, 136.1, 
135.6, 131.7, 130.2, 129.4, 128.5, 128.3, 127.0, 125.9, 121.1; HRMS Calculated for 
C26H18N6 [M+H]
+: 415.1666, Found: 415,1672. 
 
Representative procedure for the preparation of 2-(8-iodonaphthalen-1-yl)-4-
phenyl-2H-1,2,3-triazole (3-4a) (Condition B) To a solution of 1,8-diiodonaphthalene 
(760 mg, 2.0 mmol, 1.0 eq.) in dry DMSO (4 ml, 0.5 M), were added successively 4-
Phenyl-1,2,3-NH-triazole (290 mg, 2.0 mmol, 1.0 eq.) and CuI (38 mg, 10%), L-Proline 
(46 mg, 20%), K2CO3 (552 mg, 4.0 mmol, 2.0 eq.) under N2 atmosphere. The mixture 
was stirred at 80 oC and monitored by TLC. After the reaction is completed, the reaction 
was quenched with brine and extracted with ethyl acetate for three times. Organic 
phases were combined and the solvent was removed under vacuum. The residue was 
purified by flash silica gel chromatography (Hexane - EtOAc v/v 10:1), giving desired 
product as light yellow solid (yield: 401 mg, 51% ). 1H NMR (400 MHz; CDCl3): δ 8.29 
(dd, J = 7.4, 1.2 Hz, 1H), 8.21 (s, 1H), 8.04 (dd, J = 8.3, 1.3 Hz, 1H), 7.97 (dd, J = 8.3, 
1.1 Hz, 1H), 7.94-7.91 (m, 2H), 7.68 (dd, J = 7.2, 1.6 Hz, 1H), 7.59 (dd, J = 8.1, 7.3 Hz, 
1H), 7.49-7.45 (m, 2H), 7.42-7.38 (m, 1H), 7.19 (dd, J = 8.1, 7.4 Hz, 1H); 13C NMR (100 
MHz; CDCl3): δ 149.1, 143.0, 137.2, 135.8, 132.6, 132.0, 130.1, 129.5, 129.1, 128.92, 
128.75, 128.73, 127.4, 126.2, 125.2, 86.5; HRMS Calculated for C18H22N3I [M+H]
+: 
398.0149, Found: 398.0155. 
 
Representative procedure for the preparation of 1,8-bis(4-phenyl-1H-1,2,3-
triazol-1-yl)naphthalene (3-3a) To a solution of 1,8-diazidonaphthalene (420 mg, 2.0 
mmol, 1.0 eq.) in 1:1 t-BuOH/H2O (5 ml, 0.4 M), were added successively 
phenylacetylene (1.02 g, 10.0 mmol, 5.0 eq.) and CuSO4 (128 mg, 40%), and L-
Ascorbic acid sodium salt (237.6 mg, 60%) under N2 atmosphere. The mixture was 
stirred at 80oC and monitored by TLC. After the reaction is completed, the reaction was 
quenched with brine and extracted with ethyl acetate for three times. Organic phases 
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were combined and the solvent was removed under vacuum. The residue was purified 
by flash silica gel chromatography (Hexane - EtOAc v/v 5:1), giving desired product as 
light yellow solid (yield: 712 mg, 86%). 1H NMR (400 MHz; CDCl3): δ 8.25 (dd, J = 8.3, 
1.2 Hz, 1H), 7.75 (t, J = 7.8 Hz, 1H), 7.66 (dd, J = 7.6, 1.2 Hz, 1H), 7.56 (s, 1H), 7.47-
7.43 (m, 2H), 7.25-7.21 (m, 3H); 13C NMR (100 MHz; d6-DMSO): δ 146.4, 135.7, 132.1, 
131.7, 130.5, 129.4, 128.7, 128.0, 127.0, 125.8, 124.4; HRMS Calculated for C26H18N6 
[M+H]+: 415.1665, Found: 415.1677. 
Representative procedure for the preparation of 2,3'-(naphthalene-1,8-
diyl)bis(5-phenyl-2H-1,2,3-triazole) (3-3b) 2-(8-azidonaphthalen-1-yl)-4-phenyl-2H-
1,2,3-triazole is prepared from 1-azido-8-iodonaphthalene under condition B. Then to a 
solution of 2-(8-azidonaphthalen-1-yl)-4-phenyl-2H-1,2,3-triazole (624 mg, 2.0 mmol, 
1.0 eq) in 1:1 t-BuOH/H2O (5 ml, 0.4 M), were added successively phenylacetylene (510 
mg, 5.0 mmol, 2.5 eq.) and CuSO4 (64 mg, 20%), and L-Ascorbic acid sodium salt 
(118.8 mg, 30%) under N2 atmosphere. The mixture was stirred at 120 
oC and 
monitored by TLC. After the reaction is completed, the reaction was quenched with 
brine and extracted with ethyl acetate for three times. Organic phases were combined 
and the solvent was removed under vacuum. The residue was purified by flash silica gel 
chromatography (Hexane - EtOAc v/v 3:1), giving desired product as light yellow solid 
(yield: 605 mg, 73%). 1H NMR (400 MHz; CDCl3): δ 8.17 (dd, J = 7.5, 5.2 Hz, 2H), 7.84 
(d, J = 7.2 Hz, 1H), 7.79 (d, J = 7.1 Hz, 1H), 7.72 (t, J = 7.8 Hz, 2H), 7.63 (s, 1H), 7.52 
(s, 1H), 7.45 (ddd, J = 12.2, 6.4, 2.7 Hz, 4H), 7.26-7.24 (t, J =3.0 Hz 3H), 7.18 (t, J = 2.8 
Hz, 3H); 13C NMR (100 MHz; CDCl3): δ 149.0, 146.9, 135.8, 135.0, 132.4, 132.0, 131.1, 
130.8, 129.7, 129.1, 128.52, 128.48, 128.38, 128.25, 128.08, 127.7, 126.16, 126.12, 
126.04, 125.5, 122.3, 121.6, 116.0; HRMS Calculated for C26H18N6 [M+H]
+: 415.1665, 
Found: 415.1672. 
 
Representative procedure for the preparation of 1,8-bis(4-(4-chlorophenyl)-2H-
1,2,3-triazol-2-yl)naphthalene (3-5a) (Condition A) To a solution of 1,8-
diiodonaphthalene (760 mg, 2.0 mmol, 1.0 eq.) in dry DMSO (4 ml, 0.5 M), were added 
successively 4-(4-chlorophenyl)-1,2,3-NH-triazole (898 mg, 5.0 mmol, 2.5 eq.) and CuI 
(76 mg, 20%), L-Proline (92 mg, 40%), and K2CO3 (1.1 g, 8.0 mmol, 4.0 eq.) under N2 
atmosphere. The mixture was stirred at 120 oC and monitored by TLC. After the reaction 
is completed, the reaction was quenched with brine and extracted with ethyl acetate for 
three times. Organic phases were combined and the solvent was removed under 
vacuum. The residue was purified by flash silica gel chromatography (Hexane - EtOAc 
v/v 5:1), giving desired product as light yellow solid (yield: 580 mg, 60%). 1H NMR (400 
MHz; CDCl3): δ 8.14 (dd, J = 8.4, 1.1 Hz, 2H), 7.95 (dd, J = 7.4, 1.2 Hz, 2H), 7.72 (dd, J 
= 8.1, 7.6 Hz, 2H), 7.56 (s, 2H), 7.42-7.39 (m, 4H), 7.24-7.22 (m, 4H); 13C NMR (100 
MHz; CDCl3): δ 147.1, 136.0, 135.3, 134.3, 131.44, 131.41, 130.4, 128.7, 127.8, 127.07, 
127.00, 126.0, 121.0; HRMS Calculated for C26H16N6Cl2 [M+H]
+: 483.0887, Found: 
483.0897. 
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Representative procedure for the preparation of 1,8-bis(4-(4-methoxyphenyl)-
2H-1,2,3-triazol-2-yl)naphthalene (3-5b) (Condition A) To a solution of 1,8-
diiodonaphthalene (760 mg, 2.0 mmol, 1.0 eq.) in dry DMSO (4 ml, 0.5 M), were added 
successively 4-(4-methoxyphenyl)-1,2,3-NH-triazole (875 mg, 5.0 mmol, 2.5 eq.) and 
CuI (76 mg, 20%), L-Proline (92 mg, 40%), and K2CO3 (1.1 g, 8.0 mmol, 4.0 eq.) under 
N2 atmosphere. The mixture was stirred at 120 
oC and monitored by TLC. After the 
reaction is completed, the reaction was quenched with brine and extracted with ethyl 
acetate for three times. Organic phases were combined and the solvent was removed 
under vacuum. The residue was purified by flash silica gel chromatography (Hexane - 
EtOAc v/v 5:1), giving desired product as light yellow solid (yield: 607 mg, 64%). 1H 
NMR (400 MHz; CDCl3): δ 8.10 (dd, J = 8.4, 1.2 Hz, 2H), 7.94 (dd, J = 7.4, 1.2 Hz, 2H), 
7.69 (dd, J = 8.2, 7.4 Hz, 2H), 7.50 (s, 2H), 7.44-7.40 (m, 4H), 6.80-6.76 (m, 4H), 3.80 
(s, 6H); 13C NMR (100 MHz; CDCl3): δ 159.6, 148.0, 136.0, 135.6, 131.1, 130.0, 127.2, 
126.9, 125.9, 122.2, 121.2, 113.8, 55.1; HRMS Calculated for C28H22N6O2 [M+H]
+: 
475.1877, Found: 475.1883. 
 
Representative procedure for the preparation of dimethyl 4,4'-(2,2'-
(naphthalene-1,8-diyl)bis(2H-1,2,3-triazole-4,2-diyl))dibenzoate (3-5c) (Condition A) 
To a solution of 1,8-diiodonaphthalene (760 mg, 2.0 mmol, 1.0 eq.) in dry DMSO (4 ml, 
0.5 M), were added successively 4-(1H-1,2,3-triazole-4-yl)-benzoic acid methyl ester 
(1.015 g, 5.0 mmol, 2.5 eq.) and CuI (76 mg, 20%), L-Proline (92 mg, 40%), and K2CO3 
(1.1 g, 8.0 mmol, 4.0 eq.) under N2 atmosphere. The mixture was stirred at 120 
oC and 
monitored by TLC. After the reaction is completed, the reaction was quenched with 
brine and extracted with ethyl acetate for three times. Organic phases were combined 
and the solvent was removed under vacuum. The residue was purified by flash silica gel 
chromatography (Hexane - EtOAc v/v 5:1), giving desired product as light yellow solid 
(yield: 456 mg, 43%). 1H NMR (400 MHz; CDCl3): δ 8.15 (d, J = 8.2 Hz, 2H), 7.96 (d, J = 
7.4 Hz, 2H), 7.86 (d, J = 8.2 Hz, 4H), 7.73 (t, J = 7.8 Hz, 2H), 7.62 (s, 2H), 7.51 (d, J = 
8.3 Hz, 4H), 3.91 (s, 6H); 13C NMR (100 MHz; CDCl3): δ 166.5, 147.2, 136.0, 135.2, 
133.5, 132.01, 131.96, 130.5, 129.82, 129.69, 127.2, 126.0, 125.5, 121.0, 52.1; HRMS 
Calculated for C30H22N6O4 [M+Na]
+: 553.1595, Found: 553.1600. 
 
Representative procedure for the preparation of 4,4'-(2,2'-(naphthalene-1,8-
diyl)bis(2H-1,2,3-triazole-4,2-diyl))dibenzonitrile (3-5d) (Condition A) To a solution 
of 1,8-diiodonaphthalene (760 mg, 2.0 mmol, 1.0 eq.) in dry DMSO (4 ml, 0.5 M), were 
added successively 4-(2H-1,2,3-triazol-4-yl)-benzonitrile (850 mg, 5.0 mmol, 2.5 eq.) 
and CuI (76 mg, 20%), L-Proline (92 mg, 40%), and K2CO3 (1.1 g, 8.0 mmol, 4.0 eq.) 
under N2 atmosphere. The mixture was stirred at 120 
oC and monitored by TLC. After 
the reaction is completed, the reaction was quenched with brine and extracted with ethyl 
acetate for three times. Organic phases were combined and the solvent was removed 
under vacuum. The residue was purified by flash silica gel chromatography (Hexane - 
EtOAc v/v 5:1), giving desired product as light yellow solid (yield: 389 mg, 42%). 1H 
NMR (400 MHz; CDCl3): δ 8.18 (d, J = 8.2 Hz, 2H), 7.97 (d, J = 7.4 Hz, 2H), 7.76 (dd, J 
= 9.7, 6.0 Hz, 2H), 7.63 (s, 2H), 7.63-7.53 (m, 8H); 13C NMR (100 MHz; CDCl3): δ 146.3, 
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136.0, 135.0, 133.5, 132.4, 131.9, 130.7, 128.4, 127.1, 126.1, 120.7, 118.3, 112.0; 
HRMS Calculated for C28H16N8 [M+Na]
+: 487.1390, Found: 487.1396. 
Representative procedure for the preparation of 3-5e (Condition B and 
Condition A) To a solution of 1,8-diiodonaphthalene (760 mg, 2.0 mmol, 1.0 eq.) in dry 
DMSO (4 ml, 0.5 M), were added successively 4-(4-methoxyphenyl)-1,2,3-NH-triazole 
(350 mg, 2.0 mmol, 1.0 eq.) and CuI (38 mg, 10%), L-Proline (46 mg, 20%), K2CO3 (552 
mg, 4.0 mmol, 2.0 eq.) under N2 atmosphere. The mixture was stirred at 80 
oC and 
monitored by TLC. After the reaction is completed, the reaction was quenched with 
brine and extracted with ethyl acetate for three times. Organic phases were combined 
and the solvent was removed under vacuum. The residue was purified by flash silica gel 
chromatography (Hexane - EtOAc v/v 10:1), giving desired intermediate 2-(8-
iodonaphthalen-1-yl)-4-(4-methoxyphenyl)-2H-1,2,3-triazole as light yellow solid (yield: 
563 mg, 66%). To a solution of 2-(8-iodonaphthalen-1-yl)-4-(4-methoxyphenyl)-2H-
1,2,3-triazole (854 mg, 2.0 mmol, 1.0 eq.) in dry DMSO (4 ml, 0.5 M), were added 
successively 4-(2H-1,2,3-triazol-4-yl)-benzonitrile (850 mg, 5.0 mmol, 2.5 eq.) and CuI 
(76 mg, 20%), L-Proline (92 mg, 40%), and K2CO3 (1.1 g, 8.0 mmol, 4.0 eq.) under N2 
atmosphere. The mixture was stirred at 120 oC and monitored by TLC. After the reaction 
is completed, the reaction was quenched with brine and extracted with ethyl acetate for 
three times. Organic phases were combined and the solvent was removed under 
vacuum. The residue was purified by flash silica gel chromatography (Hexane - EtOAc 
v/v 5:1), giving desired product as light yellow solid (yield: 498 mg, 53%). 1H NMR (400 
MHz; CDCl3): δ 8.16-8.12 (m, 2H), 7.96-7.94 (m, 2H), 7.73 (ddd, J = 8.3, 7.4, 1.0 Hz, 
2H), 7.65 (s, 1H), 7.59-7.57 (m, 2H), 7.52-7.49 (m, 3H), 7.39-7.37 (m, 2H), 6.77-6.75 (m, 
2H), 3.82 (s, 3H); 13C NMR (100 MHz; CDCl3): δ 159.8, 148.1, 146.3, 136.0, 135.39, 
135.24, 133.9, 132.3, 132.05, 132.01, 131.05, 131.01, 130.6, 130.2, 127.13, 127.05, 
126.27, 126.11, 125.9, 121.8, 121.0, 118.6, 113.9, 111.5, 55.28; HRMS Calculated for 
C28H19N7O [M+Na]
+: 492.1543, Found: 492.1550. 
 
UV absorption spectra The UV-Vis spectra were measured in a 10.00mm quartz 
cell. All samples were measured as 10-6 mol/L solution of bis-N-2-aryl triazole in CH2Cl2. 
The wavelength range is between 200-600 nm. 
 
Fluorescence excitation and emission spectra Fluorescence emission and 
excitation spectra were measured in a 10.00 mm quartz cell. All samples were 
measured as a 10-6 mol/L solution of bis-N-2-aryl triazole in CH2Cl2. The emission 
spectra are obtained with an excitation wavelength around 300 to 310 nm, and the 
excitation spectra are obtained with the emission λmax according to different compounds. 
 
Quantum yield Quantum yield were calculated by using the standard 9,10-
diphenylanthracene which excited at 340 nm (Φ = 0.9) in cyclohexane. Quantum yields 
were calculated by using the following equation, where Φ is the quantum yield, Int is the 
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area of emission peak, A represents absorbance at the excitation wavelength and n is 
reflective index of the solvent. The subscript reference is the respective values of the 
standard 9,10-diphenylanthracene. The absorption of bis-N-2-aryl triazole and 9,10-
diphenylanthracene were less than 0.05 (Conc.= 10-6 mol/L). 
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II. ORTEP drawing of the crystal structures 
 
 
 
Figure 1. Perspective view of the molecular structures of the two independent 
molecules of 3c (C26H18N6) with the atom labeling scheme for the non-
hydrogen atoms. The thermal ellipsoids are scaled to 30% probability. CCDC 
number: 1037989 
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Figure 2. Perspective view of the molecular structure of 4a (C18H12N3I) with the atom 
labeling scheme for the non-hydrogen atoms.  The thermal ellipsoids are 
scaled to enclose 30% probability. CCDC number: 1037988. 
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Figure 3. Perspective view of the molecular structure of 5e (C28H19N7O) with the atom 
labeling scheme for the non-hydrogen atoms. The thermal ellipsoids are 
scaled to enclose 30% probability. CCDC number: 1038048. 
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III. The data of fluorophores with emission spectra  
Sample preparation: To a 100 ml volumetric flask was added the NBT (0.01 mmol) in 
100 ml Dichloromethane. After the NBT was absolutely dissolved, the 100μl triazole 
solution has been transferred to another 10 ml volumetric flask by using single-channel 
pipetter (20-200 μl), and was then diluted with additional 9.9 ml Dichloromethane.  
Integrated emission area: All the areas were integrated from the original spectra by FL 
Solution 2.0 software at the wavelength range that was 300 nm to 600 nm with an 
excitation wavelength around 300 to 310 nm.  
Quantum yield determination: All the quantum yields of samples were determined 
based on conc.= 10-6 mol/L 9,10-diphenylanthracene in cyclohexane (Φ = 0.9).  
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Figure 4. Fluorescence emission of NAT with different aryl groups: sample preparation: 
10-6 mol/L in DCM. 
 
 
 
Table 1. Comparison of optical properties of NATs. 
 
Absorption 
(nm) 
Excitation 
(λmax) 
Emission 
(λmax) 
Stokes 
Shift (nm) 
Φ 
3-1a 295 (0.027) 298 347 49 0.34 
3-1b 292 (0.009) - - - <0.1 
3-1c 296 (0.021) 293 379 86 0.32 
3-1d 286 (0.008) - - - <0.1 
3-1e 365 (0.029) 368 420 52 0.43 
3-1f 366 (0.022) 367 418a  51 0.27 
a Three different emission bands were observed in 3-1f fluorescence spectra. 
Peak λ=418 is the highest one. The other two peaks λ= 392 and 436. 
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Figure 5. Fluorescence emission of NBT 3-3 and triazole iodide 3-4a : sample 
preparation: 10-6    mol/L in DCM. 
 
 
Table 2. Comparison of optical properties of NBT 3-3 and 3-4a 
 
 
Absorption 
(nm) 
Excitation 
(λmax) 
Emission 
(λmax) 
Stokes 
Shift (nm) 
Φ 
3-3a 282 (0.079) - - - <0.01 
3-3b 307 (0.073) 307 384 77 0.13 
3-3c 310 (0.063) 315 393 78 0.24 
3-4a 297(0.064) 300 378 78 0.20 
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Figure 6. Fluorescence emission of NBT 3-5 and triazole iodide 3-4a: sample 
preparation: 10-6 mol/L in DCM. 
 
Table 3.  Comparison of optical properties of NBT 3-5 and 3-4a 
 
 
Absorption 
(nm) 
Excitation 
(λmax) 
Emission 
(λmax) 
Stokes 
Shift (nm) 
Φ 
3-4a 297(0.064) 300 378 78 0.20 
3-5a 306 (0.061) 305 393 88 0.26 
3-5b 313 (0.061) 315 403 88 0.27 
3-5c 300 (0.080) 300 396 96 0.41 
3-5d 303 (0.068) 302 403 101 0.47 
3-5e 300 (0.067) 300 408 108 0.39 
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IV. Excited state lifetime  
All the sample are tested under same conditions as described above (section II). All the 
complexes were fitted with one exponential using DAS6. 
 
  
Calculated using 1 exponential 
 
The initial paramters are: 
 
 Shift Value = 0        ch;  0              sec 
 Shift Limit = 40       ch;  2.194787E-09   sec 
 
 T1 Estimate = 12.91663 ch;  7.087312E-10   sec 
 
 A Free 
 B1 Free 
 
 Prompt and decay LO = 1597   ch; 8.762689E-08   sec 
 Prompt and decay HI = 2294   ch; 1.258711E-07   sec 
 
 Background on prompt = 0 (manual) 
 Time calibration = 5.486969E-11 sec/ch 
 
The fitted parameters are: 
 
 Hi reduced to: 2254 ch 
 
 SHIFT = 0.552488      ch; 3.031484E-11  sec S.Dev = 3.574068E-12  sec 
 T1    = 10.33031      ch; 5.668208E-10  sec S.Dev = 6.771148E-12  sec 
 A     = 3.857545         S.Dev = 0.1000181 
 B1    = 0.1259739     [ 100.00 Rel.Ampl][ 1.00 Alpha] S.Dev = 2.429185E-04 
 Average Life Time = 5.668208E-10  sec 
 CHISQ = 6.337017      [ 654 degrees of freedom ] 
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Calculated using 1 exponential 
 
The initial paramters are: 
 
 Shift Value = 0        ch;  0              sec 
 Shift Limit = 40       ch;  2.194787E-09   sec 
 
 T1 Estimate = 15.02722 ch;  8.245389E-10   sec 
 
 A Free 
 B1 Free 
 
 Prompt and decay LO = 1615   ch; 8.861454E-08   sec 
 Prompt and decay HI = 1867   ch; 1.024417E-07   sec 
 
 Background on prompt = 0 (manual) 
 Time calibration = 5.486969E-11 sec/ch 
 
The fitted parameters are: 
 
 Hi reduced to: 1827 ch 
 
 SHIFT = 1.104386      ch; 6.059733E-11  sec S.Dev = 1.883257E-12  sec 
 T1    = 14.56462      ch; 7.99156E-10   sec S.Dev = 3.201433E-12  sec 
 A     = 1.621187         S.Dev = 0.2953923 
 B1    = 9.869412E-02  [ 100.00 Rel.Ampl][ 1.00 Alpha] S.Dev = 1.800729E-04 
 Average Life Time = 7.99156E-10   sec 
 CHISQ = 1.55091       [ 209 degrees of freedom ] 
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Calculated using 1 exponential 
 
The initial paramters are: 
 
 Shift Value = 0        ch;  0              sec 
 Shift Limit = 40       ch;  2.194787E-09   sec 
 
 T1 Estimate = 48.82361 ch;  2.678936E-09   sec 
 
 A Free 
 B1 Free 
 
 Prompt and decay LO = 1604   ch; 8.801098E-08   sec 
 Prompt and decay HI = 2509   ch; 1.37668E-07    sec 
 
 Background on prompt = 0 (manual) 
 Time calibration = 5.486969E-11 sec/ch 
 
The fitted parameters are: 
 
 Hi reduced to: 2469 ch 
 
 SHIFT = 6.276135      ch; 3.443696E-10  sec S.Dev = 6.684059E-12  sec 
 T1    = 43.90302      ch; 2.408945E-09  sec S.Dev = 1.631257E-11  sec 
 A     = 4.041021         S.Dev = 0.1016247 
 B1    = 0.1070184     [ 100.00 Rel.Ampl][ 1.00 Alpha] S.Dev = 7.564617E-05 
 Average Life Time = 2.408945E-09  sec 
 CHISQ = 93.08318      [ 862 degrees of freedom ] 
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Calculated using 1 exponential 
 
The initial paramters are: 
 
 Shift Value = 0        ch;  0              sec 
 Shift Limit = 40       ch;  2.194787E-09   sec 
 
 T1 Estimate = 26.07678 ch;  1.430825E-09   sec 
 
 A Free 
 B1 Free 
 
 Prompt and decay LO = 1591   ch; 8.729767E-08   sec 
 Prompt and decay HI = 2527   ch; 1.386557E-07   sec 
 
 Background on prompt = 0 (manual) 
 Time calibration = 5.486969E-11 sec/ch 
 
The fitted parameters are: 
 
 Hi reduced to: 2487 ch 
 
 SHIFT = 1.012082      ch; 5.553263E-11  sec S.Dev = 2.595552E-12  sec 
 T1    = 23.8283       ch; 1.307451E-09  sec S.Dev = 5.174642E-12  sec 
 A     = 1.111919         S.Dev = 6.266093E-02 
 B1    = 7.393724E-02  [ 100.00 Rel.Ampl][ 1.00 Alpha] S.Dev = 1.202585E-04 
 Average Life Time = 1.307451E-09  sec 
 CHISQ = 2.872091      [ 893 degrees of freedom ] 
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Calculated using 1 exponential 
 
The initial paramters are: 
 
 Shift Value = 0        ch;  0              sec 
 Shift Limit = 40       ch;  2.194787E-09   sec 
 
 T1 Estimate = 29.85876 ch;  1.638341E-09   sec 
 
 A Free 
 B1 Free 
 
 Prompt and decay LO = 1599   ch; 8.773662E-08   sec 
 Prompt and decay HI = 2209   ch; 1.212071E-07   sec 
 
 Background on prompt = 0 (manual) 
 Time calibration = 5.486969E-11 sec/ch 
 
The fitted parameters are: 
 
 Hi reduced to: 2169 ch 
 
 SHIFT = 1.210837      ch; 6.643825E-11  sec S.Dev = 2.213482E-12  sec 
 T1    = 28.58036      ch; 1.568195E-09  sec S.Dev = 4.21055E-12   sec 
 A     = 1.481617         S.Dev = 0.1002949 
 B1    = 6.720192E-02  [ 100.00 Rel.Ampl][ 1.00 Alpha] S.Dev = 1.043928E-04 
 Average Life Time = 1.568195E-09  sec 
 CHISQ = 1.729513      [ 567 degrees of freedom ] 
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Calculated using 1 exponential 
 
The initial paramters are: 
 
 Shift Value = 0        ch;  0              sec 
 Shift Limit = 40       ch;  2.194787E-09   sec 
 
 T1 Estimate = 45.05786 ch;  2.472311E-09   sec 
 
 A Free 
 B1 Free 
 
 Prompt and decay LO = 1604   ch; 8.801098E-08   sec 
 Prompt and decay HI = 2305   ch; 1.264746E-07   sec 
 
 Background on prompt = 0 (manual) 
 Time calibration = 5.486969E-11 sec/ch 
 
The fitted parameters are: 
 
 Hi reduced to: 2265 ch 
 
 SHIFT = 0.8243643     ch; 4.523261E-11  sec S.Dev = 2.415798E-12  sec 
 T1    = 44.52381      ch; 2.443007E-09  sec S.Dev = 5.735076E-12  sec 
 A     = 0.6034257        S.Dev = 9.464832E-02 
 B1    = 5.459966E-02  [ 100.00 Rel.Ampl][ 1.00 Alpha] S.Dev = 7.483848E-05 
 Average Life Time = 2.443007E-09  sec 
 CHISQ = 2.016362      [ 658 degrees of freedom ] 
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V NMR spectra  
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